| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.69e-06 | 4 | 151 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.35e-06 | 31 | 151 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 3.42e-06 | 84 | 151 | 7 | GO:0003684 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 8.34e-06 | 6 | 151 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 8.85e-06 | 18 | 151 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.03e-05 | 230 | 151 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | NAD+-protein-serine ADP-ribosyltransferase activity | 5.68e-05 | 2 | 151 | 2 | GO:0140805 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.01e-04 | 98 | 151 | 6 | GO:0031491 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.08e-04 | 33 | 151 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 1.12e-04 | 100 | 151 | 6 | GO:0030527 | |
| GeneOntologyMolecularFunction | chromatin binding | H1-10 PARP2 ASH1L BRD3 SIN3A PHF8 MED1 CIC PARP1 TNRC18 NFKB1 PRKAA1 PKNOX1 SMARCB1 H3-3A MLLT6 | 1.55e-04 | 739 | 151 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | NAD DNA ADP-ribosyltransferase activity | 1.70e-04 | 3 | 151 | 2 | GO:0140294 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 2.56e-04 | 41 | 151 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | NAD+-protein-glutamate ADP-ribosyltransferase activity | 3.37e-04 | 4 | 151 | 2 | GO:0140807 | |
| GeneOntologyMolecularFunction | NAD+-protein-aspartate ADP-ribosyltransferase activity | 5.60e-04 | 5 | 151 | 2 | GO:0140806 | |
| GeneOntologyMolecularFunction | supercoiled DNA binding | 8.35e-04 | 6 | 151 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.03e-03 | 151 | 151 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | bubble DNA binding | 1.54e-03 | 8 | 151 | 2 | GO:0000405 | |
| GeneOntologyBiologicalProcess | chromatin organization | H1-10 PADI4 RBBP5 SMCHD1 PARP2 ASH1L HMGB1 HMGB2 BRD3 SIN3A PHF8 H3-4 UBN2 H3C15 AXIN1 PCGF6 H3C1 PRKAA1 BANP SMARCB1 H3-3A MLLT6 SPTY2D1 | 1.56e-07 | 896 | 151 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H1-10 PADI4 RBBP5 SMCHD1 PARP2 ASH1L HMGB1 HMGB2 BRD3 SIN3A PHF8 MED1 H3-4 UBN2 H3C15 AXIN1 PCGF6 H3C1 PRKAA1 BANP SMARCB1 H3-3A MLLT6 SPTY2D1 | 2.72e-07 | 999 | 151 | 24 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H1-10 PADI4 RBBP5 SMCHD1 PARP2 ASH1L HMGB1 HMGB2 BRD3 SIN3A PHF8 H3-4 H3C15 AXIN1 PCGF6 H3C1 PRKAA1 SMARCB1 H3-3A SPTY2D1 | 5.00e-07 | 741 | 151 | 20 | GO:0006338 |
| GeneOntologyBiologicalProcess | nucleosome organization | 1.04e-06 | 142 | 151 | 9 | GO:0034728 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H1-10 PADI4 HMGB1 HMGB2 MED1 H3-4 H3C15 H3C1 SMARCB1 H3-3A SPTY2D1 | 2.31e-06 | 249 | 151 | 11 | GO:0065004 |
| GeneOntologyBiologicalProcess | nucleosome assembly | 3.26e-06 | 122 | 151 | 8 | GO:0006334 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 3.91e-06 | 125 | 151 | 8 | GO:0043279 | |
| GeneOntologyBiologicalProcess | response to ATP | 1.05e-05 | 40 | 151 | 5 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 1.05e-05 | 40 | 151 | 5 | GO:0071312 | |
| GeneOntologyBiologicalProcess | negative regulation of tubulin deacetylation | 1.32e-05 | 7 | 151 | 3 | GO:1904428 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 1.50e-05 | 21 | 151 | 4 | GO:0071318 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.50e-05 | 21 | 151 | 4 | GO:0031000 | |
| GeneOntologyBiologicalProcess | tubulin deacetylation | 2.62e-05 | 24 | 151 | 4 | GO:0090042 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 6.08e-05 | 11 | 151 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.32e-04 | 14 | 151 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | positive regulation of mismatch repair | 1.59e-04 | 3 | 151 | 2 | GO:0032425 | |
| GeneOntologyBiologicalProcess | DNA ADP-ribosylation | 1.59e-04 | 3 | 151 | 2 | GO:0030592 | |
| GeneOntologyBiologicalProcess | chromosome organization | H1-10 FLNA PNKP MAPT SMCHD1 MEIKIN HMGB1 HMGB2 XRCC5 PARP1 H3C1 SMARCB1 H3-3A POLDIP2 KIF18B | 1.59e-04 | 686 | 151 | 15 | GO:0051276 |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | RBBP5 SMCHD1 HMGB1 SIN3A PHF8 AXIN1 H3C1 SMARCB1 H3-3A SPTY2D1 | 1.64e-04 | 330 | 151 | 10 | GO:0040029 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.25e-04 | 166 | 151 | 7 | GO:0014074 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | SP1 TRPV1 NRDC BARD1 HMGB1 HMGB2 MED1 ADAR TUB STAT4 AXIN1 ALMS1 STRAP PRKAA1 PKNOX1 MLLT6 IFT80 CADPS2 VPS13B | 2.27e-04 | 1043 | 151 | 19 | GO:0048871 |
| GeneOntologyBiologicalProcess | double-strand break repair via nonhomologous end joining | 2.54e-04 | 77 | 151 | 5 | GO:0006303 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TRPV1 GBP6 NKX6-2 NACA HMGB1 ZNF205 HMGB2 SIN3A MED1 PPID CIC PCGF6 PARP1 ZNF608 STRAP NFKB1 ZNF746 ARID5B SP5 | 2.56e-04 | 1053 | 151 | 19 | GO:0000122 |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 2.87e-04 | 79 | 151 | 5 | GO:0006360 | |
| GeneOntologyBiologicalProcess | adipose tissue development | 2.87e-04 | 79 | 151 | 5 | GO:0060612 | |
| GeneOntologyBiologicalProcess | regulation of mismatch repair | 3.16e-04 | 4 | 151 | 2 | GO:0032423 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 3.16e-04 | 4 | 151 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 3.42e-04 | 19 | 151 | 3 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 3.42e-04 | 19 | 151 | 3 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 3.42e-04 | 19 | 151 | 3 | GO:0086014 | |
| GeneOntologyBiologicalProcess | base-excision repair | 3.55e-04 | 46 | 151 | 4 | GO:0006284 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 3.85e-04 | 47 | 151 | 4 | GO:0006476 | |
| GeneOntologyBiologicalProcess | regulation of adipose tissue development | 4.64e-04 | 21 | 151 | 3 | GO:1904177 | |
| GeneOntologyBiologicalProcess | response to hydroperoxide | 4.64e-04 | 21 | 151 | 3 | GO:0033194 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SP1 MYT1 NACA ASH1L ZNF629 HMGB1 ISL2 HMGB2 BRD3 PHF8 MED1 STAT4 PARP1 LMX1A CDK13 NFKB1 ZNF746 PKNOX1 SMARCB1 AATF MLLT6 EN2 | 5.05e-04 | 1390 | 151 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | TRPM4 SP1 FLNA TRPV1 CASP6 SIN3A MED1 RYR1 RYR2 RYR3 PARP1 NFKB1 SP5 | 5.20e-04 | 605 | 151 | 13 | GO:0071407 |
| GeneOntologyBiologicalProcess | receptor localization to non-motile cilium | 5.25e-04 | 5 | 151 | 2 | GO:0097500 | |
| GeneOntologyBiologicalProcess | regulation of tubulin deacetylation | 5.35e-04 | 22 | 151 | 3 | GO:0090043 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FLNA TRPV1 GBP6 NKX6-2 NACA HMGB1 ZNF205 HMGB2 SIN3A MED1 XRCC5 PPID CIC AXIN1 PCGF6 PARP1 ZNF608 STRAP NFKB1 ZNF746 ARID5B SP5 | 5.50e-04 | 1399 | 151 | 22 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FLNA TRPV1 GBP6 NKX6-2 NACA HMGB1 ZNF205 HMGB2 SIN3A MED1 XRCC5 PPID CIC AXIN1 PCGF6 PARP1 ZNF608 STRAP NFKB1 ZNF746 ARID5B SP5 | 6.29e-04 | 1413 | 151 | 22 | GO:1902679 |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 6.31e-04 | 197 | 151 | 7 | GO:0002244 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 6.39e-04 | 392 | 151 | 10 | GO:0070588 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 6.53e-04 | 143 | 151 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | TRPM4 SP1 FLNA TRPV1 CASP6 HMGB1 HMGB2 SIN3A MED1 RYR1 RYR2 RYR3 PARP1 NFKB1 PRKAA1 ASPH SP5 PRKCG | 6.70e-04 | 1048 | 151 | 18 | GO:0014070 |
| GeneOntologyCellularComponent | chromatin | H1-10 SP1 NKX6-2 MYT1 ISL2 HMGB2 BRD3 XPC SIN3A MED1 H3-4 H3-7 H3C15 CIC STAT4 SP8 PARP1 H3C1 LMX1A NFKB1 PRKAA1 PKNOX1 SMARCB1 SP5 H3-3A EN2 | 2.96e-05 | 1480 | 154 | 26 | GO:0000785 |
| Domain | Ryanodine_rcpt | 4.88e-07 | 3 | 148 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.88e-07 | 3 | 148 | 3 | IPR009460 | |
| Domain | RyR | 4.88e-07 | 3 | 148 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 4.88e-07 | 3 | 148 | 3 | PF06459 | |
| Domain | Ryan_recept | 4.88e-07 | 3 | 148 | 3 | IPR013333 | |
| Domain | RIH_assoc-dom | 9.58e-06 | 6 | 148 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 9.58e-06 | 6 | 148 | 3 | PF08709 | |
| Domain | RIH_assoc | 9.58e-06 | 6 | 148 | 3 | PF08454 | |
| Domain | RIH_dom | 9.58e-06 | 6 | 148 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.58e-06 | 6 | 148 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.58e-06 | 6 | 148 | 3 | IPR015925 | |
| Domain | - | 9.58e-06 | 6 | 148 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 9.58e-06 | 6 | 148 | 3 | PF01365 | |
| Domain | HISTONE_H3_1 | 1.67e-05 | 7 | 148 | 3 | PS00322 | |
| Domain | HISTONE_H3_2 | 2.65e-05 | 8 | 148 | 3 | PS00959 | |
| Domain | Histone_H3/CENP-A | 2.65e-05 | 8 | 148 | 3 | IPR000164 | |
| Domain | H3 | 2.65e-05 | 8 | 148 | 3 | SM00428 | |
| Domain | MIR | 5.62e-05 | 10 | 148 | 3 | PF02815 | |
| Domain | MIR_motif | 5.62e-05 | 10 | 148 | 3 | IPR016093 | |
| Domain | Sp1_fam | 5.62e-05 | 10 | 148 | 3 | IPR030450 | |
| Domain | MIR | 5.62e-05 | 10 | 148 | 3 | PS50919 | |
| Domain | MIR | 5.62e-05 | 10 | 148 | 3 | SM00472 | |
| Domain | WGR | 1.86e-04 | 3 | 148 | 2 | SM00773 | |
| Domain | PARP_reg | 1.86e-04 | 3 | 148 | 2 | PF02877 | |
| Domain | TAU_MAP_2 | 1.86e-04 | 3 | 148 | 2 | PS51491 | |
| Domain | Tubulin-binding | 1.86e-04 | 3 | 148 | 2 | PF00418 | |
| Domain | WGR | 1.86e-04 | 3 | 148 | 2 | PF05406 | |
| Domain | MAP_tubulin-bd_rpt | 1.86e-04 | 3 | 148 | 2 | IPR001084 | |
| Domain | TAU_MAP_1 | 1.86e-04 | 3 | 148 | 2 | PS00229 | |
| Domain | MAP2/MAP4/Tau | 1.86e-04 | 3 | 148 | 2 | IPR027324 | |
| Domain | HMG_boxA_CS | 1.86e-04 | 3 | 148 | 2 | IPR017967 | |
| Domain | - | 1.86e-04 | 3 | 148 | 2 | 2.20.140.10 | |
| Domain | Pecanex_C | 3.70e-04 | 4 | 148 | 2 | PF05041 | |
| Domain | PARP_ALPHA_HD | 3.70e-04 | 4 | 148 | 2 | PS51060 | |
| Domain | Poly(ADP-ribose)pol_reg_dom | 3.70e-04 | 4 | 148 | 2 | IPR004102 | |
| Domain | - | 3.70e-04 | 4 | 148 | 2 | 1.20.142.10 | |
| Domain | Pecanex | 3.70e-04 | 4 | 148 | 2 | IPR007735 | |
| Domain | DUF1041 | 6.14e-04 | 5 | 148 | 2 | SM01145 | |
| Domain | - | 1.14e-03 | 261 | 148 | 8 | 1.10.238.10 | |
| Domain | DEATH | 1.24e-03 | 27 | 148 | 3 | SM00005 | |
| Domain | Munc13_1 | 1.28e-03 | 7 | 148 | 2 | IPR014770 | |
| Domain | MHD1 | 1.28e-03 | 7 | 148 | 2 | PS51258 | |
| Domain | DUF1041 | 1.28e-03 | 7 | 148 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.28e-03 | 7 | 148 | 2 | IPR010439 | |
| Domain | EF-hand-dom_pair | 2.08e-03 | 287 | 148 | 8 | IPR011992 | |
| Domain | Ion_trans_dom | 2.15e-03 | 114 | 148 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.15e-03 | 114 | 148 | 5 | PF00520 | |
| Domain | HMG_box_2 | 2.16e-03 | 9 | 148 | 2 | PF09011 | |
| Domain | Death | 2.23e-03 | 33 | 148 | 3 | PF00531 | |
| Domain | EF_hand_dom | 2.54e-03 | 232 | 148 | 7 | IPR002048 | |
| Domain | IG_FLMN | 2.69e-03 | 10 | 148 | 2 | SM00557 | |
| Domain | HMG_BOX_1 | 2.69e-03 | 10 | 148 | 2 | PS00353 | |
| Domain | Filamin | 3.27e-03 | 11 | 148 | 2 | PF00630 | |
| Domain | BAH | 3.27e-03 | 11 | 148 | 2 | PS51038 | |
| Domain | FILAMIN_REPEAT | 3.27e-03 | 11 | 148 | 2 | PS50194 | |
| Domain | FYVE_2 | 3.27e-03 | 11 | 148 | 2 | PF02318 | |
| Domain | Filamin/ABP280_rpt | 3.27e-03 | 11 | 148 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.27e-03 | 11 | 148 | 2 | IPR017868 | |
| Domain | BAH_dom | 3.27e-03 | 11 | 148 | 2 | IPR001025 | |
| Domain | BAH | 3.27e-03 | 11 | 148 | 2 | SM00439 | |
| Domain | BAH | 3.27e-03 | 11 | 148 | 2 | PF01426 | |
| Domain | Death_domain | 3.36e-03 | 38 | 148 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 3.36e-03 | 38 | 148 | 3 | PS50017 | |
| Domain | RABBD | 3.91e-03 | 12 | 148 | 2 | PS50916 | |
| Domain | Rab_BD | 3.91e-03 | 12 | 148 | 2 | IPR010911 | |
| Domain | C2 | 3.91e-03 | 131 | 148 | 5 | PF00168 | |
| Domain | C2 | 4.72e-03 | 137 | 148 | 5 | SM00239 | |
| Domain | C2 | 5.49e-03 | 142 | 148 | 5 | PS50004 | |
| Domain | Znf_FYVE_PHD | 6.34e-03 | 147 | 148 | 5 | IPR011011 | |
| Domain | - | 6.41e-03 | 93 | 148 | 4 | 1.10.533.10 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 7.85e-03 | 17 | 148 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 7.85e-03 | 17 | 148 | 2 | PS51059 | |
| Domain | PARP | 7.85e-03 | 17 | 148 | 2 | PF00644 | |
| Domain | - | 7.85e-03 | 17 | 148 | 2 | 3.90.228.10 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.16e-05 | 19 | 108 | 4 | M47760 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGH_MMSET_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 1.16e-05 | 19 | 108 | 4 | M47442 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE | 3.55e-05 | 9 | 108 | 3 | M47830 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.64e-05 | 54 | 108 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.64e-05 | 54 | 108 | 5 | MM15202 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 6.90e-05 | 11 | 108 | 3 | M47958 | |
| Pathway | WP_BASE_EXCISION_REPAIR | 8.74e-05 | 31 | 108 | 4 | M39861 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.11e-04 | 99 | 108 | 6 | MM14910 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.18e-04 | 13 | 108 | 3 | M39589 | |
| Pathway | KEGG_BASE_EXCISION_REPAIR | 1.42e-04 | 35 | 108 | 4 | M5500 | |
| Pathway | PID_TELOMERASE_PATHWAY | 1.59e-04 | 67 | 108 | 5 | M105 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.61e-04 | 106 | 108 | 6 | M27200 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.96e-04 | 70 | 108 | 5 | M27231 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 2.39e-04 | 73 | 108 | 5 | M27166 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.40e-04 | 272 | 108 | 9 | M29619 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 3.17e-04 | 120 | 108 | 6 | M40049 | |
| Pathway | BIOCARTA_CHEMICAL_PATHWAY | 3.28e-04 | 18 | 108 | 3 | MM1350 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 3.88e-04 | 19 | 108 | 3 | M39450 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.92e-04 | 175 | 108 | 7 | MM14941 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.06e-04 | 176 | 108 | 7 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.13e-04 | 183 | 108 | 7 | M997 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 5.29e-04 | 49 | 108 | 4 | MM15448 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 5.72e-04 | 50 | 108 | 4 | M27232 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 6.06e-04 | 22 | 108 | 3 | M39795 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 6.63e-04 | 91 | 108 | 5 | M27101 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 6.65e-04 | 52 | 108 | 4 | M2341 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | SP1 RBBP5 BARD1 ZNF205 SIN3A MED1 PCGF6 PARP1 CDK13 ZNF746 PRKAA1 BANP CYCS SMARCB1 H3-3A | 7.42e-04 | 768 | 108 | 15 | MM14851 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 8.45e-04 | 96 | 108 | 5 | M27792 | |
| Pathway | BIOCARTA_HIVNEF_PATHWAY | 8.81e-04 | 56 | 108 | 4 | MM1406 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 8.90e-04 | 25 | 108 | 3 | MM1359 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | H1-10 SP1 PNKP RBBP5 SMCHD1 PARP2 POLR1C ZNF629 BARD1 HMGB1 ZNF205 BRD3 XPC SIN3A PHF8 MED1 XRCC5 UBN2 ADAR CIC PCGF6 PARP1 PPIG RBM25 TIGD2 H3C1 CDK13 RRP9 AHNAK BANP ASPH ARID5B HNRNPA0 SMARCB1 AATF CKAP4 LAS1L KIF18B SPTY2D1 | 1.11e-21 | 1294 | 155 | 39 | 30804502 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | H1-10 FLNA FLNB ABCF1 MAP4 SMCHD1 SIPA1L3 PARP2 NACA ETF1 POLR1C HMGB1 EXOSC8 HMGB2 XRCC5 ADAR AFAP1L1 PARP1 RBM25 H3C1 STRAP RRP9 SLC25A1 AHNAK ASPH HNRNPA0 NAV1 AATF CKAP4 LAS1L IQGAP3 | 7.21e-15 | 1257 | 155 | 31 | 36526897 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | H1-10 ABCF1 MAP4 MYO9B SMCHD1 NACA POLR1C ZNF629 BARD1 EXOSC8 SIN3A PHF8 MED1 XRCC5 ADAR STRAP CDK13 RRP9 ASPH AATF CKAP4 LAS1L SPTY2D1 IQGAP3 | 5.91e-14 | 759 | 155 | 24 | 35915203 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H1-10 FLNA MAP4 SMCHD1 HMGB1 HMGB2 MED1 XRCC5 H3-4 UBN2 ADAR H3C15 CIC HMGB1P1 PARP1 RBM25 H3C1 AHNAK CYCS HNRNPA0 H3-3A AATF MLLT6 CKAP4 LAS1L KIF18B | 1.47e-13 | 954 | 155 | 26 | 36373674 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | UBR1 H1-10 ABCF1 MAP4 MYO9B PARP2 NACA POLR1C PTDSS1 PHF8 XRCC5 PARP1 RBM25 SLC25A1 ASPH HNRNPA0 SMARCB1 CKAP4 IQGAP3 | 7.62e-13 | 486 | 155 | 19 | 30940648 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | H1-10 PNKP RBBP5 SMCHD1 PARP2 HMGB2 BRD3 XPC SIN3A MED1 XRCC5 PARP1 AHNAK HNRNPA0 SMARCB1 AATF KIF18B | 2.77e-12 | 394 | 155 | 17 | 27248496 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | H1-10 FLNA FLNB ABCF1 MAP4 PARP2 NACA PTDSS1 XRCC5 H3-4 ADAR H3-7 H3C15 PARP1 RBM25 H3C1 CDK13 SLC25A1 AHNAK HNRNPA0 AATF CKAP4 LAS1L DUSP11 | 6.73e-12 | 949 | 155 | 24 | 36574265 |
| Pubmed | H1-10 SP1 RBBP5 SMCHD1 NACA ZNF629 HMGB1 ISL2 HMGB2 SIN3A GIGYF1 PHF8 XRCC5 UBN2 CIC STAT4 PCGF6 RBM25 ALMS1 ZNF608 STRAP NFKB1 ZNF746 BANP ARID5B SMARCB1 MLLT6 POLDIP2 LAS1L | 7.36e-12 | 1429 | 155 | 29 | 35140242 | |
| Pubmed | FLNB NPEPPS SMCHD1 PARP2 ZNF629 BARD1 EXOSC8 HMGB2 BRD3 XPC MED1 UBN2 H3C1 ALMS1 ZNF608 AHNAK CYCS NAV1 POLDIP2 KIF18B | 1.23e-11 | 645 | 155 | 20 | 25281560 | |
| Pubmed | 3.44e-11 | 15 | 155 | 6 | 28190768 | ||
| Pubmed | FLNA FLNB PHACTR2 NLRP7 SMCHD1 SIPA1L3 ASH1L HMGB1 HMGB2 BRD3 XPC XRCC5 H3-4 H3C15 RYR2 PARP1 TNRC18 H3C1 ZNF608 CDK13 SLC25A1 AHNAK CYCS HNRNPA0 H3-3A AATF CADPS2 ATP2B3 | 4.95e-11 | 1442 | 155 | 28 | 35575683 | |
| Pubmed | UBR1 H1-10 FLNA PNKP ABCF1 MAP4 MYO9B NPEPPS SIPA1L3 ETF1 POLR1C HMGB1 HMGB2 MED1 XRCC5 PPID AXIN1 PARP1 PPIG TNRC18 RBM25 H3C1 ZNF608 SLC25A1 HNRNPA0 MLLT6 | 5.77e-11 | 1247 | 155 | 26 | 27684187 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 H1-10 FLNA FLNB ABCF1 MAP4 MYO9B NPEPPS SMCHD1 NACA POLR1C AAK1 XPC PHF8 XRCC5 ADAR H3-7 PCGF6 PARP1 SLC25A1 AHNAK ASPH HNRNPA0 AATF CKAP4 LAS1L KIF18B | 6.27e-11 | 1353 | 155 | 27 | 29467282 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | FLNA FLNB PNKP ABCF1 MAP4 MAPT SMCHD1 AAK1 PARP1 H3C1 CDK13 SLC25A1 AHNAK HNRNPA0 NAV1 SMARCB1 CKAP4 | 1.08e-10 | 498 | 155 | 17 | 36634849 |
| Pubmed | TRPM4 PNKP ABCF1 MAP4 RBBP5 SIPA1L3 PARP2 NACA POLR1C PTDSS1 AAK1 EXOSC8 BRD3 XPC MED1 UBN2 H3C15 CIC H3C1 CDK13 RRP9 SLC25A1 ASPH AATF LAS1L SPTY2D1 IQGAP3 DUSP11 | 1.17e-10 | 1497 | 155 | 28 | 31527615 | |
| Pubmed | PNKP MAP4 RBBP5 SMCHD1 ETF1 POLR1C HMGB1 HMGB2 BRD3 SIN3A PHF8 MED1 XRCC5 ADAR PPID PARP1 PPIG RBM25 H3C1 CDK13 AHNAK SMARCB1 H3-3A | 1.65e-10 | 1014 | 155 | 23 | 32416067 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RBBP5 SMCHD1 BARD1 EXOSC8 BRD3 XPC SIN3A PHF8 MED1 XRCC5 UBN2 CIC PCGF6 PARP1 SMARCB1 H3-3A MLLT6 KIF18B | 2.94e-10 | 608 | 155 | 18 | 36089195 |
| Pubmed | H1-10 FLNA FLNB ABCF1 MAP4 RBBP5 NPEPPS SMCHD1 NACA HMGB1 HMGB2 XRCC5 PARP1 H3C1 RRP9 ASPH HNRNPA0 H3-3A CKAP4 | 5.05e-10 | 711 | 155 | 19 | 33022573 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | H1-10 FLNA FLNB ABCF1 MAP4 HMGB1 HMGB2 XRCC5 ADAR PARP1 PPIG RBM25 STRAP CDK13 RRP9 HNRNPA0 AATF CKAP4 LAS1L DUSP11 | 6.30e-10 | 807 | 155 | 20 | 22681889 |
| Pubmed | Human PAD4 regulates histone arginine methylation levels via demethylimination. | 7.45e-10 | 11 | 155 | 5 | 15345777 | |
| Pubmed | H1-10 PNKP ETF1 POLR1C EXOSC8 XRCC5 H3-4 ADAR PARP1 CDK13 RRP9 HNRNPA0 AATF LAS1L DUSP11 | 7.48e-10 | 419 | 155 | 15 | 15635413 | |
| Pubmed | FLNA ABCF1 MAP4 NPEPPS SMCHD1 ETF1 ZNF629 HMGB1 ISL2 HMGB2 SIN3A MED1 UBN2 ADAR CIC PARP1 TNRC18 STRAP CDK13 HNRNPA0 SMARCB1 H3-3A MLLT6 | 8.35e-10 | 1103 | 155 | 23 | 34189442 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | H1-10 FLNA ABCF1 MAP4 SMCHD1 PARP2 NACA ETF1 POLR1C PTDSS1 HMGB1 XRCC5 ADAR PARP1 PPIG RBM25 H3C1 RRP9 SLC25A1 AHNAK HNRNPA0 SMARCB1 H3-3A AATF LAS1L | 9.91e-10 | 1318 | 155 | 25 | 30463901 |
| Pubmed | FLNA FLNB PNKP ABCF1 SMCHD1 SIPA1L3 NACA POLR1C XRCC5 ADAR PARP1 PPIG RBM25 H3C1 STRAP RRP9 AHNAK HNRNPA0 | 1.08e-09 | 660 | 155 | 18 | 32780723 | |
| Pubmed | H1-10 FLNB RBBP5 POLR1C PTDSS1 ZNF629 EXOSC8 BRD3 XPC XRCC5 ADAR RBM25 STRAP RRP9 ASPH HNRNPA0 SMARCB1 AATF CKAP4 LAS1L | 1.44e-09 | 847 | 155 | 20 | 35850772 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 H1-10 SP1 FLNA ABCF1 MAP4 MAPT AAK1 ISL2 BRD3 XPC SIN3A PHF8 MED1 CIC PPIG RBM25 CDK13 ASPH | 2.04e-09 | 774 | 155 | 19 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPM4 FLNB MAP4 MAPT NPEPPS MYT1 SIPA1L3 ASH1L PTDSS1 AAK1 BARD1 ANKMY1 XRCC5 UBN2 CLCC1 PCNX2 TNRC18 ZNF608 TSPAN10 CDK13 PCNX4 BANP ASPH ARID5B NAV1 VPS13B | 2.48e-09 | 1489 | 155 | 26 | 28611215 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA FLNB SMCHD1 PARP2 ETF1 POLR1C SIN3A XRCC5 ADAR H3-7 H3C15 PARP1 RBM25 RRP9 AHNAK CYCS HNRNPA0 AATF LAS1L KIF18B SPTY2D1 | 3.54e-09 | 989 | 155 | 21 | 36424410 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SP1 FLNA FLNB ABCF1 MAP4 SMCHD1 SIN3A XRCC5 PARP1 STRAP AHNAK HNRNPA0 LAS1L | 3.66e-09 | 332 | 155 | 13 | 32786267 |
| Pubmed | H1-10 FLNA GBP6 ABCF1 MAP4 SMCHD1 NACA ETF1 XRCC5 AXIN1 PARP1 RBM25 STRAP TSPAN10 AHNAK ASPH HNRNPA0 CKAP4 ALPK2 | 4.18e-09 | 809 | 155 | 19 | 32129710 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FLNA MAP4 MAPT AAK1 ZNF629 EXOSC8 XPC MED1 UBN2 ADAR PCGF6 STRAP AHNAK PRKAA1 AATF CKAP4 LAS1L KIF18B | 4.59e-09 | 724 | 155 | 18 | 36232890 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | H1-10 FLNA FLNB ABCF1 NRDC MAP4 RBBP5 NPEPPS SMCHD1 NACA ETF1 HMGB1 XRCC5 ADAR PARP1 RBM25 STRAP RRP9 CYCS HNRNPA0 H3-3A POLDIP2 CKAP4 ATP2B3 IQGAP3 | 4.77e-09 | 1425 | 155 | 25 | 30948266 |
| Pubmed | H1-10 FLNA ABCF1 POLR1C EXOSC8 XRCC5 ADAR PARP1 H3C1 STRAP CDK13 RRP9 AATF LAS1L SPTY2D1 | 5.12e-09 | 483 | 155 | 15 | 36912080 | |
| Pubmed | FLNA FLNB ABCF1 NRDC MAP4 MAPT PDK1 NPEPPS SIPA1L3 ETF1 PTDSS1 AAK1 TPPP HMGB1 DAPK1 PPFIA3 PARP1 LZTS1 PRKAA1 CYCS HNRNPA0 NAV1 PRKCG ATP2B3 UNC13A | 5.19e-09 | 1431 | 155 | 25 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | H1-10 FLNA FLNB ABCF1 MAP4 MYO9B NPEPPS SMCHD1 NACA XRCC5 ADAR H3C15 PARP1 RBM25 RRP9 AHNAK PRKAA1 HNRNPA0 AATF CKAP4 LAS1L | 6.50e-09 | 1024 | 155 | 21 | 24711643 |
| Pubmed | UBR1 FLNA FLNB MAP4 RBBP5 NPEPPS NACA BARD1 EXOSC8 XRCC5 PARP1 ALMS1 STRAP AHNAK HNRNPA0 | 6.92e-09 | 494 | 155 | 15 | 26831064 | |
| Pubmed | FLNA MAP4 NPEPPS SMCHD1 SIPA1L3 NACA AAK1 XPC MED1 XRCC5 PARP1 PPIG RBM25 STRAP CDK13 SLC25A1 AHNAK ASPH SMARCB1 AATF CKAP4 LAS1L SPTY2D1 DUSP11 | 1.05e-08 | 1371 | 155 | 24 | 36244648 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ABCF1 PDK1 PTDSS1 ZNF629 HMGB1 EXOSC8 BRD3 XPC MED1 XRCC5 ADAR PARP1 PPIG RBM25 SLC25A1 CYCS HNRNPA0 SMARCB1 POLDIP2 CKAP4 UNC13A | 1.68e-08 | 1082 | 155 | 21 | 38697112 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | H1-10 FLNA FLNB ABCF1 NRDC MAP4 SMCHD1 NACA ETF1 POLR1C PTDSS1 SIN3A XRCC5 PARP1 STRAP CDK13 SLC25A1 AHNAK PRKAA1 ASPH HNRNPA0 NAV1 POLDIP2 CKAP4 | 1.91e-08 | 1415 | 155 | 24 | 28515276 |
| Pubmed | FLNA FLNB ABCF1 MAP4 SMCHD1 NACA POLR1C HMGB1 HMGB2 XRCC5 H3C15 PPID PARP1 STRAP SLC25A1 AHNAK HNRNPA0 | 2.06e-08 | 707 | 155 | 17 | 19738201 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | H1-10 FLNA PTDSS1 ZNF629 HMGB1 ZNF205 XPC SIN3A XRCC5 H3C15 CLCC1 AXIN1 PARP1 H3C1 ZNF608 AHNAK ASPH CYCS ARID5B FAM3C CKAP4 DUSP11 | 2.14e-08 | 1203 | 155 | 22 | 29180619 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.76e-08 | 202 | 155 | 10 | 33005030 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.89e-08 | 203 | 155 | 10 | 22083510 | |
| Pubmed | H1-10 FLNA FLNB SMCHD1 NACA POLR1C BARD1 XRCC5 ADAR H3-7 H3C15 PARP1 AHNAK HNRNPA0 H3-3A CKAP4 | 4.16e-08 | 652 | 155 | 16 | 31180492 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | RBBP5 SMCHD1 NACA PTDSS1 SIN3A XRCC5 ADAR STRAP SLC25A1 POLDIP2 | 5.42e-08 | 217 | 155 | 10 | 31685992 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | H1-10 FLNA FLNB NPEPPS SMCHD1 ETF1 BARD1 EXOSC8 XRCC5 RBM25 ALMS1 STRAP CDK13 PREP CKAP4 LAS1L | 6.03e-08 | 670 | 155 | 16 | 22990118 |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 18403125 | ||
| Pubmed | Identification of the core-histone-binding domains of HMG1 and HMG2. | 8.68e-08 | 3 | 155 | 3 | 3697355 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 8.68e-08 | 3 | 155 | 3 | 9204703 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 8.68e-08 | 3 | 155 | 3 | 12213830 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 25239916 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 11159936 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7959768 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7635066 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7876312 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 8.68e-08 | 3 | 155 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 8.68e-08 | 3 | 155 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 8.68e-08 | 3 | 155 | 3 | 10473538 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9242641 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 18643873 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 8.68e-08 | 3 | 155 | 3 | 4600883 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 FLNA TBC1D9B MYO9B SIPA1L3 POMGNT1 EXOSC8 PLXND1 TNFRSF21 CIC RYR1 PCNX2 TNRC18 CDK13 PCNX4 AHNAK BANP NAV1 MLLT6 IQGAP3 | 1.17e-07 | 1105 | 155 | 20 | 35748872 |
| Pubmed | 1.22e-07 | 52 | 155 | 6 | 23182705 | ||
| Pubmed | 1.22e-07 | 11 | 155 | 4 | 15471871 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | PNKP ABCF1 MYO9B SMCHD1 ASH1L BRD3 PHF8 MED1 RBM25 H3C1 PCNX4 SMARCB1 AATF LAS1L | 1.34e-07 | 533 | 155 | 14 | 30554943 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | H1-10 FLNA FLNB ABCF1 NPEPPS ETF1 ASH1L HMGB1 DAPK1 HMGB2 XRCC5 RYR1 PARP1 STRAP SLC25A1 AHNAK IQGAP3 | 1.37e-07 | 807 | 155 | 17 | 30575818 |
| Pubmed | SP1 MYT1 ASH1L HMGB1 ISL2 ZNF205 BRD3 PHF8 CIC STAT4 LMX1A NFKB1 ARID5B PKNOX1 SMARCB1 AATF MLLT6 | 1.39e-07 | 808 | 155 | 17 | 20412781 | |
| Pubmed | ABCF1 NACA POLR1C PTDSS1 AAK1 ZNF629 SIN3A ADAR PPID RBM25 AHNAK ASPH POLDIP2 CKAP4 | 1.83e-07 | 547 | 155 | 14 | 37267103 | |
| Pubmed | SP1 WDR64 BARD1 XPC PPFIA3 MED1 DNAH7 CIC RYR1 RYR2 LZTS1 ARID5B SMARCB1 AATF ATP2B3 | 1.95e-07 | 638 | 155 | 15 | 31182584 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 FLNA FLNB ABCF1 MAP4 NPEPPS NACA ETF1 POLR1C AAK1 EXOSC8 SIN3A XRCC5 ADAR PPID CLCC1 PARP1 SLC25A1 AHNAK NFKB1 PRKAA1 AATF | 1.97e-07 | 1367 | 155 | 22 | 32687490 |
| Pubmed | 2.10e-07 | 251 | 155 | 10 | 31076518 | ||
| Pubmed | FLNA FLNB ABCF1 RGS7BP MYO9B NACA XRCC5 H3-4 H3-7 H3C15 H3C1 SLC25A1 AHNAK PRKAA1 H3-3A POLDIP2 CKAP4 | 2.56e-07 | 844 | 155 | 17 | 25963833 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLNA FLNB NACA ETF1 HMGB1 HMGB2 XRCC5 ADAR HMGB1P1 AXIN1 PARP1 RBM25 H3C1 STRAP HNRNPA0 SMARCB1 H3-3A | 2.69e-07 | 847 | 155 | 17 | 35235311 |
| Pubmed | FLNA FLNB RBBP5 MYO9B ADAR PARP1 TNRC18 AHNAK NFKB1 NAV1 ALPK2 | 3.24e-07 | 332 | 155 | 11 | 37433992 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.46e-07 | 4 | 155 | 3 | 23413940 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 9607712 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 23482488 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 18206662 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 9384575 | ||
| Pubmed | 3.67e-07 | 14 | 155 | 4 | 16267050 | ||
| Pubmed | RBBP5 SMCHD1 SIN3A MED1 UBN2 CIC TNRC18 ZNF608 ARID5B SMARCB1 | 3.84e-07 | 268 | 155 | 10 | 33640491 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 3.98e-07 | 269 | 155 | 10 | 29511261 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | H1-10 SP1 NKX6-2 ASH1L BARD1 ISL2 SIN3A MED1 CIC SP8 PCGF6 PARP1 ZNF556 LMX1A NFKB1 PKNOX1 AATF | 4.37e-07 | 877 | 155 | 17 | 20211142 |
| Pubmed | 4.42e-07 | 152 | 155 | 8 | 16009940 | ||
| Pubmed | FLNA FLNB PNKP TBC1D9B RBBP5 NPEPPS PARP2 NACA POLR1C HMGB1 ISL2 XRCC5 UBN2 CLCC1 PARP1 STRAP AHNAK NFKB1 ASPH HNRNPA0 CKAP4 LAS1L | 4.74e-07 | 1440 | 155 | 22 | 30833792 | |
| Pubmed | 6.23e-07 | 159 | 155 | 8 | 34537242 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.96e-07 | 220 | 155 | 9 | 35785414 | |
| Pubmed | H1-10 FLNA ABCF1 MAP4 NACA MED1 XRCC5 ADAR H3C15 PARP1 RBM25 HNRNPA0 | 7.54e-07 | 441 | 155 | 12 | 31239290 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 8.63e-07 | 5 | 155 | 3 | 19011160 | |
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 7309716 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 23918386 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 16185088 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | FLNA LRRC66 MYO9B SMCHD1 SIPA1L3 PARP2 HMGB1 DAPK1 HMGB2 XRCC5 AXIN1 STRAP NFKB1 ZNF746 HNRNPA0 EN2 IQGAP3 | 8.68e-07 | 922 | 155 | 17 | 27609421 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNA FLNB SIPA1L3 NACA XRCC5 H3-4 ADAR H3C15 PARP1 H3C1 STRAP AHNAK BANP H3-3A | 9.16e-07 | 626 | 155 | 14 | 33644029 |
| Pubmed | 1.03e-06 | 74 | 155 | 6 | 35102251 | ||
| Pubmed | 1.03e-06 | 74 | 155 | 6 | 36180920 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA ABCF1 MAP4 SMCHD1 NACA ETF1 AAK1 SIN3A MED1 XRCC5 ADAR CIC PARP1 ALMS1 STRAP AHNAK CYCS | 1.04e-06 | 934 | 155 | 17 | 33916271 |
| Interaction | PARP1 interactions | SP1 PNKP MAPT SMCHD1 PARP2 POLR1C BARD1 HMGB1 DAPK1 HMGB2 BRD3 XPC SIN3A PHF8 MED1 XRCC5 H3-4 ADAR H3C15 CIC PARP1 RBM25 H3C1 STRAP CDK13 SLC25A1 NFKB1 ZNF746 PRKAA1 BANP PKNOX1 SMARCB1 H3-3A AATF MLLT6 CKAP4 LAS1L KIF18B IQGAP3 | 1.18e-13 | 1316 | 154 | 39 | int:PARP1 |
| Interaction | H3C1 interactions | H1-10 MAPT RBBP5 SMCHD1 PARP2 NACA ASH1L BARD1 HMGB1 HMGB2 BRD3 XPC SIN3A PHF8 XRCC5 H3-4 UBN2 H3-7 H3C15 PCGF6 PARP1 TNRC18 H3C1 CDK13 AHNAK HNRNPA0 H3-3A POLDIP2 CKAP4 KIF18B | 7.82e-12 | 901 | 154 | 30 | int:H3C1 |
| Interaction | HMGA1 interactions | H1-10 SP1 RBBP5 PDK1 PARP2 BARD1 HMGB1 HMGB2 XPC XRCC5 H3-4 UBN2 H3-7 H3C15 HMGB1P1 PARP1 TNRC18 H3C1 NFKB1 SMARCB1 H3-3A | 9.27e-12 | 419 | 154 | 21 | int:HMGA1 |
| Interaction | BRD7 interactions | UBR1 H1-10 ABCF1 MAP4 MYO9B PARP2 NACA POLR1C PTDSS1 BARD1 BRD3 PHF8 XRCC5 H3-4 H3C15 PARP1 RBM25 H3C1 SLC25A1 ASPH HNRNPA0 SMARCB1 H3-3A CKAP4 IQGAP3 | 1.72e-11 | 637 | 154 | 25 | int:BRD7 |
| Interaction | H3-3A interactions | MAPT RBBP5 SMCHD1 PARP2 ASH1L BARD1 HMGB1 EXOSC8 HMGB2 BRD3 XPC SIN3A PHF8 MED1 XRCC5 H3-4 UBN2 H3C15 CIC PCGF6 PARP1 H3C1 SMARCB1 H3-3A MLLT6 KIF18B | 9.60e-11 | 749 | 154 | 26 | int:H3-3A |
| Interaction | H2AC4 interactions | H1-10 PNKP MAPT RBBP5 PARP2 BARD1 XPC XRCC5 H3-4 H3-7 H3C15 PARP1 H3C1 ALMS1 ARID5B HNRNPA0 SMARCB1 H3-3A AATF KIF18B ATP2B3 | 3.05e-10 | 506 | 154 | 21 | int:H2AC4 |
| Interaction | HMGN5 interactions | H1-10 RBBP5 SMCHD1 PARP2 BARD1 XPC XRCC5 H3C15 PARP1 H3C1 RRP9 H3-3A | 2.43e-09 | 154 | 154 | 12 | int:HMGN5 |
| Interaction | CEBPB interactions | H1-10 SP1 FLNA FLNB PNKP ABCF1 MAP4 NPEPPS SMCHD1 NACA ETF1 POLR1C HMGB1 HMGB2 XPC SIN3A MED1 XRCC5 H3-4 ADAR H3-7 H3C15 CIC PARP1 RBM25 STRAP CDK13 AHNAK NFKB1 CYCS HNRNPA0 SMARCB1 AATF LAS1L | 2.74e-09 | 1443 | 154 | 34 | int:CEBPB |
| Interaction | WDR5 interactions | H1-10 SP1 FLNA FLNB ABCF1 MAP4 RBBP5 NPEPPS SMCHD1 NACA BARD1 HMGB1 HMGB2 SIN3A PHF8 XRCC5 H3-4 CIC PCGF6 PARP1 H3C1 ZNF608 STRAP RRP9 ASPH HNRNPA0 SMARCB1 H3-3A CKAP4 | 4.32e-09 | 1101 | 154 | 29 | int:WDR5 |
| Interaction | CENPA interactions | H1-10 SMCHD1 PARP2 HMGB1 HMGB2 BRD3 XPC PHF8 XRCC5 UBN2 H3-7 PARP1 H3-3A AATF MLLT6 LAS1L KIF18B | 4.95e-09 | 377 | 154 | 17 | int:CENPA |
| Interaction | NPM1 interactions | H1-10 SP1 FLNA FLNB PADI4 NLRP7 MAPT MYO9B MYT1 PARP2 POLR1C BARD1 HMGB1 EXOSC8 BRD3 XPC XRCC5 H3-4 ADAR PPID CIC PARP1 H3C1 ZNF746 BANP HNRNPA0 AATF LAS1L SPTY2D1 DUSP11 | 7.57e-09 | 1201 | 154 | 30 | int:NPM1 |
| Interaction | H4C9 interactions | 1.03e-08 | 108 | 154 | 10 | int:H4C9 | |
| Interaction | HMGA2 interactions | 1.05e-08 | 140 | 154 | 11 | int:HMGA2 | |
| Interaction | H2BC3 interactions | PNKP RBBP5 PARP2 BARD1 HMGB2 BRD3 XPC SIN3A MED1 XRCC5 PARP1 H3C1 AHNAK ZNF746 HNRNPA0 SMARCB1 KIF18B | 1.48e-08 | 406 | 154 | 17 | int:H2BC3 |
| Interaction | HMGN2 interactions | ABCF1 NLRP7 PARP2 TPPP BARD1 BRD3 PHF8 H3-4 H3-7 H3C15 PARP1 PPIG H3C1 | 1.65e-08 | 222 | 154 | 13 | int:HMGN2 |
| Interaction | H1-5 interactions | H1-10 GBP6 MAP4 MYO9B CYP3A43 PARP2 PTDSS1 TPPP HMGB1 PHF8 H3-4 H3-7 H3C15 AXIN1 PARP1 H3C1 CDK13 H3-3A | 1.71e-08 | 463 | 154 | 18 | int:H1-5 |
| Interaction | SOX2 interactions | H1-10 FLNA NRDC RBBP5 MYO9B NPEPPS SMCHD1 SIPA1L3 ISL2 SIN3A MED1 XRCC5 UBN2 ADAR CIC RYR1 PARP1 TNRC18 ZNF608 STRAP LZTS1 PREP RRP9 SLC25A1 ASPH ARID5B HNRNPA0 SMARCB1 POLDIP2 CKAP4 LAS1L IQGAP3 | 2.63e-08 | 1422 | 154 | 32 | int:SOX2 |
| Interaction | TFAP4 interactions | SP1 PARP2 HMGB1 EXOSC8 HMGB2 SIN3A XRCC5 UBN2 CIC PKNOX1 SMARCB1 | 2.66e-08 | 153 | 154 | 11 | int:TFAP4 |
| Interaction | HECTD1 interactions | H1-10 ABCF1 MAP4 MYO9B SMCHD1 NACA POLR1C ZNF629 BARD1 EXOSC8 SIN3A PHF8 MED1 XRCC5 ADAR PARP1 RBM25 STRAP CDK13 RRP9 ASPH AATF CKAP4 LAS1L SPTY2D1 IQGAP3 | 2.90e-08 | 984 | 154 | 26 | int:HECTD1 |
| Interaction | SMC5 interactions | H1-10 FLNA MAP4 SMCHD1 HMGB1 HMGB2 MED1 XRCC5 H3-4 UBN2 ADAR H3C15 CIC HMGB1P1 PARP1 RBM25 H3C1 AHNAK CYCS HNRNPA0 H3-3A AATF MLLT6 CKAP4 LAS1L KIF18B | 4.00e-08 | 1000 | 154 | 26 | int:SMC5 |
| Interaction | WDR76 interactions | FLNA FLNB RBBP5 SMCHD1 PARP2 POLR1C HMGB1 BRD3 XPC XRCC5 H3-7 PCGF6 PARP1 H3C1 HNRNPA0 H3-3A | 4.17e-08 | 383 | 154 | 16 | int:WDR76 |
| Interaction | H3-4 interactions | H1-10 PADI4 ABCF1 RBBP5 PARP2 SIN3A PHF8 H3-4 H3C15 PCGF6 PARP1 H3C1 CDK13 AHNAK ZNF746 H3-3A VPS13B | 6.21e-08 | 448 | 154 | 17 | int:H3-4 |
| Interaction | NR3C1 interactions | UBR1 SP1 WDR64 SMCHD1 BARD1 HMGB1 DAPK1 HMGB2 XPC PPFIA3 MED1 PPID DNAH7 CIC RYR1 RYR2 PARP1 H3C1 LZTS1 NFKB1 ARID5B SMARCB1 AATF CKAP4 ATP2B3 | 9.69e-08 | 974 | 154 | 25 | int:NR3C1 |
| Interaction | POU5F1 interactions | SP1 FLNA FLNB ABCF1 RBBP5 SMCHD1 NACA ETF1 HMGB1 HMGB2 BRD3 XPC SIN3A XRCC5 UBN2 H3C15 PARP1 AHNAK SMARCB1 | 1.12e-07 | 584 | 154 | 19 | int:POU5F1 |
| Interaction | SRPK2 interactions | MAP4 MAPT SMCHD1 SIPA1L3 PTDSS1 BARD1 EXOSC8 BRD3 XRCC5 ADAR PPIG ANOS1 AMMECR1L ALMS1 CDK13 RRP9 SLC25A1 PRKAA1 AATF LAS1L CADPS2 | 1.34e-07 | 717 | 154 | 21 | int:SRPK2 |
| Interaction | SUMO2 interactions | SP1 FLNA FLNB ABCF1 MAP4 SMCHD1 NACA BRD3 SIN3A PHF8 XRCC5 CIC HMGB1P1 PARP1 STRAP AHNAK HNRNPA0 LAS1L KIF18B | 1.34e-07 | 591 | 154 | 19 | int:SUMO2 |
| Interaction | H2AX interactions | TRPV1 PARP2 NACA BARD1 BRD3 XPC SIN3A XRCC5 H3-4 H3-7 H3C15 TUB PARP1 TNRC18 H3C1 RRP9 BANP SMARCB1 H3-3A | 1.42e-07 | 593 | 154 | 19 | int:H2AX |
| Interaction | CIT interactions | H1-10 FLNA FLNB PNKP ABCF1 RBBP5 MYO9B NPEPPS SMCHD1 NACA POLR1C ASH1L BRD3 SIN3A PLXND1 MED1 XRCC5 ADAR H3C15 RBM25 ALMS1 RRP9 SLC25A1 AHNAK MROH2B ASPH HNRNPA0 AATF POLDIP2 CKAP4 LAS1L | 1.44e-07 | 1450 | 154 | 31 | int:CIT |
| Interaction | H2AZ1 interactions | ABCF1 MAPT RBBP5 PARP2 HMGB1 BRD3 XPC SIN3A XRCC5 H3-4 H3C15 PARP1 H3C1 ARID5B SMARCB1 | 1.72e-07 | 371 | 154 | 15 | int:H2AZ1 |
| Interaction | DOT1L interactions | H1-10 FLNB POLR1C PTDSS1 ZNF629 EXOSC8 BRD3 XPC XRCC5 H3-4 ADAR RBM25 STRAP RRP9 ASPH HNRNPA0 SMARCB1 H3-3A AATF MLLT6 CKAP4 LAS1L | 2.25e-07 | 807 | 154 | 22 | int:DOT1L |
| Interaction | H2AC21 interactions | H1-10 NLRP7 MAP4 HMGB1 BRD3 XPC H3-4 H3-7 H3C15 PARP1 ANOS1 H3C1 | 2.54e-07 | 234 | 154 | 12 | int:H2AC21 |
| Interaction | MEN1 interactions | H1-10 RBBP5 SMCHD1 POLR1C PTDSS1 ZNF629 EXOSC8 XPC SIN3A PHF8 MED1 XRCC5 H3-4 ADAR RBM25 H3C1 ZNF608 STRAP NFKB1 ASPH SMARCB1 H3-3A AATF CKAP4 LAS1L | 2.74e-07 | 1029 | 154 | 25 | int:MEN1 |
| Interaction | ATM interactions | PNKP NRDC MAPT XPC SIN3A MED1 XRCC5 PARP1 H3C1 NFKB1 PRKAA1 BANP SMARCB1 AATF | 2.83e-07 | 333 | 154 | 14 | int:ATM |
| Interaction | SUPT16H interactions | PNKP RBBP5 HMGB1 HMGB2 BRD3 XPC MED1 XRCC5 H3C15 CIC PARP1 RBM25 H3C1 PRKAA1 SMARCB1 H3-3A | 2.93e-07 | 442 | 154 | 16 | int:SUPT16H |
| Interaction | HDAC1 interactions | SP1 FLNA FLNB PADI4 RBBP5 MYT1 PARP2 HMGB1 SIN3A H3-4 CIC PCGF6 PARP1 TNRC18 RBM25 H3C1 ALMS1 ZNF608 STRAP AHNAK NFKB1 BANP ARID5B NAV1 SMARCB1 H3-3A | 2.99e-07 | 1108 | 154 | 26 | int:HDAC1 |
| Interaction | H2AC12 interactions | 3.09e-07 | 118 | 154 | 9 | int:H2AC12 | |
| Interaction | H2BC9 interactions | H1-10 PHACTR2 ABCF1 ASH1L HMGB1 DAPK1 HMGB2 H3-4 H3-7 H3C15 PARP1 TNRC18 H3C1 AHNAK H3-3A ATP2B3 | 3.31e-07 | 446 | 154 | 16 | int:H2BC9 |
| Interaction | H2BC21 interactions | H1-10 PNKP RBBP5 SMCHD1 PARP2 BARD1 XPC PHF8 XRCC5 H3-4 H3-7 H3C15 PARP1 H3C1 AHNAK SMARCB1 H3-3A CKAP4 KIF18B ATP2B3 | 3.70e-07 | 696 | 154 | 20 | int:H2BC21 |
| Interaction | TNIP1 interactions | H1-10 FLNA FLNB PNKP ABCF1 MAP4 PARP2 NACA PTDSS1 HMGB2 XRCC5 H3-4 ADAR H3-7 H3C15 PARP1 RBM25 H3C1 CDK13 SLC25A1 AHNAK NFKB1 HNRNPA0 AATF CKAP4 LAS1L DUSP11 | 5.16e-07 | 1217 | 154 | 27 | int:TNIP1 |
| Interaction | LRRC31 interactions | FLNA FLNB MAP4 MYO9B SMCHD1 PTDSS1 MED1 XRCC5 PARP1 AHNAK IQGAP3 | 5.21e-07 | 205 | 154 | 11 | int:LRRC31 |
| Interaction | AR interactions | SP1 FLNA RBBP5 SMCHD1 HMGB1 HMGB2 BRD3 SIN3A MED1 XRCC5 UBN2 ADAR PPID CIC PARP1 TNRC18 RBM25 ZNF608 NFKB1 ARID5B HNRNPA0 SMARCB1 H3-3A AATF | 5.27e-07 | 992 | 154 | 24 | int:AR |
| Interaction | SNCA interactions | FLNA FLNB PNKP ABCF1 MAP4 MAPT SMCHD1 AAK1 TPPP SIN3A PARP1 H3C1 CDK13 PREP SLC25A1 AHNAK CYCS HNRNPA0 NAV1 SMARCB1 | 5.77e-07 | 716 | 154 | 20 | int:SNCA |
| Interaction | XPC interactions | 6.78e-07 | 168 | 154 | 10 | int:XPC | |
| Interaction | H2BC4 interactions | H1-10 ABCF1 MAP4 SMCHD1 PARP2 H3-4 H3C15 PARP1 TNRC18 H3C1 H3-3A FAM3C | 7.50e-07 | 259 | 154 | 12 | int:H2BC4 |
| Interaction | HPF1 interactions | 7.55e-07 | 42 | 154 | 6 | int:HPF1 | |
| Interaction | USP36 interactions | H1-10 FLNA ABCF1 RBBP5 POLR1C EXOSC8 XRCC5 ADAR PARP1 ANOS1 H3C1 STRAP CDK13 RRP9 CYCS AATF LAS1L SPTY2D1 | 7.85e-07 | 599 | 154 | 18 | int:USP36 |
| Interaction | MYB interactions | 8.54e-07 | 133 | 154 | 9 | int:MYB | |
| Interaction | ING2 interactions | 8.71e-07 | 68 | 154 | 7 | int:ING2 | |
| Interaction | H4C6 interactions | 9.63e-07 | 69 | 154 | 7 | int:H4C6 | |
| Interaction | NUPR1 interactions | FLNA FLNB PNKP ABCF1 NPY5R SMCHD1 SIPA1L3 NACA POLR1C XRCC5 ADAR PARP1 PPIG RBM25 H3C1 STRAP RRP9 AHNAK HNRNPA0 | 1.20e-06 | 683 | 154 | 19 | int:NUPR1 |
| Interaction | H2BC12 interactions | H1-10 ABCF1 MAP4 MAPT SMCHD1 H3-4 H3C15 CIC TNRC18 H3C1 AHNAK H3-3A FAM3C | 1.21e-06 | 322 | 154 | 13 | int:H2BC12 |
| Interaction | CHAF1A interactions | NRDC DAPK1 HMGB2 BRD3 XPC SIN3A XRCC5 H3-4 PCGF6 H3C1 SMARCB1 H3-3A LAS1L | 1.21e-06 | 322 | 154 | 13 | int:CHAF1A |
| Interaction | H3C3 interactions | RBBP5 SMCHD1 BARD1 BRD3 XPC SIN3A PHF8 MED1 XRCC5 H3-7 CIC PCGF6 PARP1 SMARCB1 MLLT6 KIF18B | 1.31e-06 | 495 | 154 | 16 | int:H3C3 |
| Interaction | APLF interactions | 1.50e-06 | 47 | 154 | 6 | int:APLF | |
| Interaction | EFTUD2 interactions | H1-10 FLNA FLNB ABCF1 MAP4 RBBP5 SMCHD1 NACA ETF1 POLR1C PTDSS1 HMGB1 SIN3A XRCC5 CIC PARP1 H3C1 STRAP CDK13 SLC25A1 AHNAK ZNF746 PRKAA1 ASPH HNRNPA0 NAV1 SMARCB1 POLDIP2 CKAP4 | 1.51e-06 | 1449 | 154 | 29 | int:EFTUD2 |
| Interaction | MECP2 interactions | SP1 ABCF1 RBBP5 PDK1 PTDSS1 ZNF629 HMGB1 EXOSC8 BRD3 XPC SIN3A MED1 XRCC5 ADAR H3C15 PARP1 PPIG RBM25 H3C1 SLC25A1 CYCS HNRNPA0 SMARCB1 H3-3A POLDIP2 CKAP4 UNC13A | 1.52e-06 | 1287 | 154 | 27 | int:MECP2 |
| Interaction | H3-5 interactions | 2.69e-06 | 114 | 154 | 8 | int:H3-5 | |
| Interaction | RNF4 interactions | H1-10 SP1 FLNA PTDSS1 ZNF629 HMGB1 ZNF205 XPC SIN3A BTBD1 XRCC5 H3C15 CLCC1 AXIN1 PARP1 RBM25 H3C1 ZNF608 AHNAK ZNF746 ASPH CYCS ARID5B HNRNPA0 H3-3A FAM3C CKAP4 DUSP11 | 2.82e-06 | 1412 | 154 | 28 | int:RNF4 |
| Interaction | ZNF428 interactions | 2.98e-06 | 30 | 154 | 5 | int:ZNF428 | |
| Interaction | TAF4 interactions | 3.22e-06 | 156 | 154 | 9 | int:TAF4 | |
| Interaction | LRIF1 interactions | SMCHD1 NACA POLR1C BARD1 HMGB1 H3-4 PCGF6 PARP1 H3C1 BANP H3-3A | 3.23e-06 | 247 | 154 | 11 | int:LRIF1 |
| Interaction | PPP1CB interactions | FLNA FLNB NLRP7 MAP4 MAPT SIPA1L3 RYR2 PARP1 H3C1 CDK13 NFKB1 SMARCB1 H3-3A AATF KIF18B | 3.25e-06 | 469 | 154 | 15 | int:PPP1CB |
| Interaction | UHRF2 interactions | SMCHD1 HMGB1 HMGB2 BRD3 XRCC5 PARP1 H3C1 AHNAK HNRNPA0 H3-3A | 3.29e-06 | 200 | 154 | 10 | int:UHRF2 |
| Interaction | H4C12 interactions | 3.45e-06 | 54 | 154 | 6 | int:H4C12 | |
| Interaction | H1-2 interactions | H1-10 FLNA GBP6 MYO9B HMGB2 H3-4 H3-7 H3C15 AXIN1 PARP1 ANOS1 H3C1 AHNAK ZNF746 ASPH H3-3A AATF CKAP4 | 3.51e-06 | 666 | 154 | 18 | int:H1-2 |
| Interaction | KIF23 interactions | FLNA FLNB ABCF1 MYO9B POLR1C XRCC5 ADAR TNFRSF21 PARP1 PPIG TNRC18 RBM25 H3C1 ALMS1 AHNAK ASPH H3-3A AATF POLDIP2 CKAP4 ATP2B3 SPTY2D1 IQGAP3 | 3.68e-06 | 1031 | 154 | 23 | int:KIF23 |
| Interaction | RBPJ interactions | 4.22e-06 | 254 | 154 | 11 | int:RBPJ | |
| Interaction | H1-0 interactions | H1-10 RBBP5 PARP2 BRD3 H3-4 H3C15 AXIN1 PARP1 H3C1 SMARCB1 H3-3A | 4.55e-06 | 256 | 154 | 11 | int:H1-0 |
| Interaction | RAG1 interactions | 4.87e-06 | 33 | 154 | 5 | int:RAG1 | |
| Interaction | RSF1 interactions | 5.04e-06 | 124 | 154 | 8 | int:RSF1 | |
| Interaction | TAF1 interactions | 5.27e-06 | 260 | 154 | 11 | int:TAF1 | |
| Interaction | MACROH2A2 interactions | 5.29e-06 | 211 | 154 | 10 | int:MACROH2A2 | |
| Interaction | BRPF3 interactions | 5.36e-06 | 166 | 154 | 9 | int:BRPF3 | |
| Interaction | KMT2A interactions | SP1 RBBP5 BRD3 SIN3A H3-4 H3C15 ANOS1 H3C1 ZNF608 SMARCB1 H3-3A LAS1L | 5.52e-06 | 314 | 154 | 12 | int:KMT2A |
| Interaction | ZNF711 interactions | 5.68e-06 | 34 | 154 | 5 | int:ZNF711 | |
| Interaction | HDAC5 interactions | FLNA NPEPPS SIN3A XRCC5 H3-4 ADAR PARP1 RBM25 H3C1 STRAP SLC25A1 NFKB1 PRKAA1 H3-3A | 6.04e-06 | 432 | 154 | 14 | int:HDAC5 |
| Interaction | MORC2 interactions | 6.28e-06 | 91 | 154 | 7 | int:MORC2 | |
| Interaction | TRIM37 interactions | FLNB PNKP MAP4 SIPA1L3 NACA GIGYF1 XRCC5 H3-4 H3-7 AXIN1 PARP1 RBM25 ALMS1 AHNAK ZNF746 NAV1 CKAP4 | 6.81e-06 | 630 | 154 | 17 | int:TRIM37 |
| Interaction | HDGF interactions | H1-10 SP1 FLNB ABCF1 MAP4 PDK1 NACA XRCC5 PARP1 H3C1 H3-3A CKAP4 | 6.91e-06 | 321 | 154 | 12 | int:HDGF |
| Interaction | BARD1 interactions | SMCHD1 BARD1 XRCC5 PARP1 RBM25 H3C1 STRAP CDK13 NFKB1 SMARCB1 H3-3A LAS1L | 7.36e-06 | 323 | 154 | 12 | int:BARD1 |
| Interaction | EP300 interactions | SP1 FLNA ABCF1 NRDC MAP4 MAPT RBBP5 NACA POLR1C HMGB1 HMGB2 SIN3A MED1 XRCC5 H3-4 ADAR HMGB1P1 PARP1 RBM25 H3C1 STRAP NFKB1 PRKAA1 BANP SMARCB1 H3-3A CKAP4 | 7.39e-06 | 1401 | 154 | 27 | int:EP300 |
| Interaction | RBBP7 interactions | SP1 FLNA MAPT RBBP5 ASH1L SIN3A H3-4 UBN2 H3C15 CIC TNRC18 H3C1 STRAP SMARCB1 H3-3A | 8.29e-06 | 507 | 154 | 15 | int:RBBP7 |
| Interaction | ZNF330 interactions | H1-10 SMCHD1 ZNF629 HMGB1 BRD3 XPC SIN3A PHF8 PARP1 AATF MLLT6 LAS1L KIF18B SPTY2D1 | 8.67e-06 | 446 | 154 | 14 | int:ZNF330 |
| Interaction | H2BC8 interactions | RBBP5 SMCHD1 PARP2 ZNF629 BARD1 EXOSC8 HMGB2 BRD3 XPC XRCC5 H3-4 H3C15 PARP1 ARID5B LAS1L KIF18B | 9.02e-06 | 576 | 154 | 16 | int:H2BC8 |
| Interaction | CBX3 interactions | MAPT SMCHD1 ZNF629 BARD1 HMGB1 HMGB2 BRD3 XPC MED1 H3-4 UBN2 H3C15 CIC PCGF6 PARP1 H3C1 H3-3A | 9.45e-06 | 646 | 154 | 17 | int:CBX3 |
| Interaction | NEIL3 interactions | 9.59e-06 | 97 | 154 | 7 | int:NEIL3 | |
| Interaction | YY1 interactions | SP1 RBBP5 SMCHD1 HMGB1 SIN3A XRCC5 H3-4 CIC PCGF6 PARP1 RBM25 H3C1 NFKB1 H3-3A | 1.06e-05 | 454 | 154 | 14 | int:YY1 |
| Interaction | EMX2 interactions | 1.14e-05 | 39 | 154 | 5 | int:EMX2 | |
| Interaction | H1-4 interactions | RBBP5 TPPP HMGB1 PLXND1 PHF8 H3-4 H3-7 H3C15 TNRC18 H3C1 CDK13 PREP NFKB1 H3-3A AATF SPTY2D1 ALPK2 | 1.15e-05 | 656 | 154 | 17 | int:H1-4 |
| Interaction | MACROH2A1 interactions | MAPT PTDSS1 BARD1 HMGB1 BRD3 XPC SIN3A PHF8 XRCC5 H3-4 PARP1 H3C1 SMARCB1 H3-3A | 1.17e-05 | 458 | 154 | 14 | int:MACROH2A1 |
| Interaction | HMGN4 interactions | 1.17e-05 | 100 | 154 | 7 | int:HMGN4 | |
| Interaction | MYLK2 interactions | 1.25e-05 | 101 | 154 | 7 | int:MYLK2 | |
| Interaction | VIM interactions | UBR1 SP1 TBC1D9B NLRP7 MAPT CYP3A43 MEIKIN SIPA1L3 POLR1C AAK1 CASP6 HMGB1 ARMCX2 CIC CEMIP RRP9 NFKB1 NAV1 SMARCB1 | 1.26e-05 | 804 | 154 | 19 | int:VIM |
| Interaction | MAPT interactions | H1-10 FLNA PNKP ABCF1 MAP4 MAPT NPEPPS AAK1 TPPP CASP6 PPFIA3 PPID PARP1 H3C1 SLC25A1 AHNAK CYCS HNRNPA0 H3-3A PRKCG AATF CKAP4 ATP2B3 | 1.40e-05 | 1119 | 154 | 23 | int:MAPT |
| Interaction | H2AC14 interactions | 1.52e-05 | 144 | 154 | 8 | int:H2AC14 | |
| Interaction | MDC1 interactions | FLNA FLNB SMCHD1 BARD1 EXOSC8 BRD3 SIN3A XRCC5 ADAR H3C1 SMARCB1 H3-3A LAS1L | 1.83e-05 | 414 | 154 | 13 | int:MDC1 |
| Interaction | H2AC18 interactions | 1.85e-05 | 148 | 154 | 8 | int:H2AC18 | |
| Interaction | KCTD13 interactions | FLNA FLNB ABCF1 NRDC MAP4 MAPT PDK1 NPEPPS SIPA1L3 ETF1 POLR1C PTDSS1 AAK1 TPPP HMGB1 DAPK1 PPFIA3 PARP1 LZTS1 PRKAA1 CYCS HNRNPA0 NAV1 PRKCG ATP2B3 UNC13A | 1.98e-05 | 1394 | 154 | 26 | int:KCTD13 |
| Interaction | NR2C2 interactions | H1-10 FLNA ABCF1 MAP4 SMCHD1 PARP2 NACA ETF1 POLR1C PTDSS1 HMGB1 XRCC5 ADAR CIC PARP1 PPIG RBM25 H3C1 RRP9 SLC25A1 AHNAK HNRNPA0 SMARCB1 H3-3A AATF LAS1L | 2.21e-05 | 1403 | 154 | 26 | int:NR2C2 |
| Interaction | C9orf78 interactions | NRDC MAP4 MAPT RBBP5 PDK1 NPEPPS SIN3A BTBD1 ADAR CLCC1 PARP1 H3C1 PRKAA1 ASPH H3-3A LAS1L | 2.23e-05 | 620 | 154 | 16 | int:C9orf78 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.19e-07 | 3 | 110 | 3 | 287 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.79e-05 | 9 | 110 | 3 | 755 | |
| GeneFamily | Histones | 7.62e-05 | 116 | 110 | 6 | 864 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 1.60e-03 | 10 | 110 | 2 | 822 | |
| GeneFamily | Canonical high mobility group | 1.95e-03 | 11 | 110 | 2 | 511 | |
| GeneFamily | EF-hand domain containing | 2.22e-03 | 219 | 110 | 6 | 863 | |
| GeneFamily | LIM class homeoboxes | 2.33e-03 | 12 | 110 | 2 | 522 | |
| Coexpression | GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | MAP4 NPEPPS PARP2 AAK1 MED1 PPIG TNRC18 SLC25A1 AHNAK PKNOX1 | 2.79e-07 | 196 | 155 | 10 | M9515 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | UBR1 FLNA NRDC MYO9B SMCHD1 ASH1L PTDSS1 AAK1 HMGB1 SIN3A DENND1C BTBD1 MED1 XRCC5 ADAR STAT4 PCNX2 PARP1 PPIG SYTL3 CDK13 AHNAK MLLT6 VPS13B | 7.56e-06 | 1492 | 155 | 24 | M40023 |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 8.13e-06 | 170 | 155 | 8 | M5657 | |
| Coexpression | FISCHER_DREAM_TARGETS | SP1 SMCHD1 PARP2 BARD1 HMGB1 EXOSC8 HMGB2 SIN3A H3C15 ALMS1 RRP9 PRKAA1 PKNOX1 HNRNPA0 IFT80 LAS1L KIF18B IQGAP3 | 1.81e-05 | 969 | 155 | 18 | M149 |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 2.64e-05 | 200 | 155 | 8 | M5068 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN | 2.64e-05 | 200 | 155 | 8 | M5052 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | UBR1 SP1 PHACTR2 SMCHD1 MED1 PPIG ALMS1 PRKAA1 SPTY2D1 VPS13B | 1.05e-09 | 186 | 154 | 10 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.43e-08 | 200 | 154 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.64e-07 | 192 | 154 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.78e-07 | 199 | 154 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.78e-07 | 199 | 154 | 8 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.96e-07 | 200 | 154 | 8 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.96e-07 | 200 | 154 | 8 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 5.00e-06 | 193 | 154 | 7 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.72e-06 | 197 | 154 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mLN-(1)_T_cell-(11)_Activated_CD4_T|mLN / shred on region, Cell_type, and subtype | 6.11e-06 | 199 | 154 | 7 | 7da5a38f36ee10b95e07b2a8275cfb80c891d54c | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-06 | 199 | 154 | 7 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-06 | 199 | 154 | 7 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | mLN-T_cell-Activated_CD4_T|mLN / Region, Cell class and subclass | 6.11e-06 | 199 | 154 | 7 | 398eb1c809afb6ec711fb41563e11a3697730271 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.31e-06 | 200 | 154 | 7 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.31e-06 | 200 | 154 | 7 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-06 | 132 | 154 | 6 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.24e-05 | 147 | 154 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 155 | 154 | 6 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 163 | 154 | 6 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 163 | 154 | 6 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.42e-05 | 176 | 154 | 6 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.00e-05 | 181 | 154 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 154 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 154 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 154 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.94e-05 | 188 | 154 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.94e-05 | 188 | 154 | 6 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 4.94e-05 | 188 | 154 | 6 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.55e-05 | 192 | 154 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.55e-05 | 192 | 154 | 6 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-05 | 193 | 154 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.72e-05 | 193 | 154 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.05e-05 | 195 | 154 | 6 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | BLOOD--(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.05e-05 | 195 | 154 | 6 | c25391931659881d4104b06cf07cb44efa635e39 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.05e-05 | 195 | 154 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | 10x5'v1-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 6.23e-05 | 196 | 154 | 6 | 31229affb48521e8be93b6061178fd8cea09ba99 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.23e-05 | 196 | 154 | 6 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.40e-05 | 197 | 154 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | BL-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.40e-05 | 197 | 154 | 6 | fb70918867fbd111bb192a797dcafed5f39ea299 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.40e-05 | 197 | 154 | 6 | 78122e1fb80e0ac3084dd4f7c551996330a701df | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 6.40e-05 | 197 | 154 | 6 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 6.59e-05 | 198 | 154 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.59e-05 | 198 | 154 | 6 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 199 | 154 | 6 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 199 | 154 | 6 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 199 | 154 | 6 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 199 | 154 | 6 | dadee9fc6ce4f4bdb19d29326889316443dda0cb | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.77e-05 | 199 | 154 | 6 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 199 | 154 | 6 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.96e-05 | 200 | 154 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 6.96e-05 | 200 | 154 | 6 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.96e-05 | 200 | 154 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.96e-05 | 200 | 154 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.96e-05 | 200 | 154 | 6 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-C_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.96e-05 | 200 | 154 | 6 | b6b59f56497b5a58e2d4eb6a97ada75c93729716 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.96e-05 | 200 | 154 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| Drug | anti-BaPDE | SP1 FLNA PNKP CYP3A43 HMGB1 HMGB2 XPC H3-7 PPIG H3C1 NFKB1 CYCS CKAP4 | 7.44e-09 | 234 | 154 | 13 | CID000041322 |
| Drug | AC1L96VB | TRPM4 TRPV1 PNKP PARP2 CASP6 RYR1 RYR2 RYR3 PARP1 NFKB1 CYCS | 7.69e-08 | 191 | 154 | 11 | CID000439200 |
| Drug | cis-diammineplatinum(II | 3.03e-07 | 3 | 154 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.03e-07 | 3 | 154 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 3.03e-07 | 3 | 154 | 3 | CID000127713 | |
| Drug | aminodantrolene | 3.03e-07 | 3 | 154 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 3.03e-07 | 3 | 154 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.03e-07 | 3 | 154 | 3 | CID005748312 | |
| Drug | PCB74 | 1.21e-06 | 4 | 154 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.21e-06 | 4 | 154 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.21e-06 | 4 | 154 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.21e-06 | 4 | 154 | 3 | CID000035682 | |
| Drug | adenosine diphosphoribose | 3.06e-06 | 92 | 154 | 7 | CID000030243 | |
| Drug | AC1L9K70 | 3.63e-06 | 228 | 154 | 10 | CID000446871 | |
| Drug | AC1NUZLU | NOX5 PARP2 CASP6 HMGB1 PPID TNFRSF21 PARP1 NFKB1 CYCS VPS13B | 4.58e-06 | 234 | 154 | 10 | CID005497170 |
| Drug | methylcoumarin | 5.72e-06 | 18 | 154 | 4 | CID000007092 | |
| Drug | chloro-m-cresol | 5.98e-06 | 6 | 154 | 3 | CID000012008 | |
| Drug | MBED | 5.98e-06 | 6 | 154 | 3 | CID000129958 | |
| Drug | AC1O528X | 5.98e-06 | 6 | 154 | 3 | CID006475857 | |
| Drug | NSC114784 | 5.98e-06 | 6 | 154 | 3 | CID000419425 | |
| Drug | selenite | 7.73e-06 | 148 | 154 | 8 | CID000001090 | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A | 8.47e-06 | 198 | 154 | 9 | 2943_DN | |
| Drug | C070379 | 8.82e-06 | 199 | 154 | 9 | CID003034747 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.04e-05 | 7 | 154 | 3 | CID009547999 | |
| Drug | Azumoleno | 1.04e-05 | 7 | 154 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 1.04e-05 | 7 | 154 | 3 | CID003081001 | |
| Drug | AC1L3UEY | 1.20e-05 | 113 | 154 | 7 | CID000122342 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | FLNA PADI4 MOGAT1 RGS7BP FAM13C SMCHD1 MYT1 BARD1 DAPK1 HMGB2 PPFIA3 ITPRID1 UBN2 RYR1 CEMIP PARP1 FAT2 TNRC18 H3C1 SYTL5 ASPH CKAP4 KIF18B ATP2B3 IQGAP3 | 1.29e-05 | 1441 | 154 | 25 | ctd:C009828 |
| Drug | wortmannin | 1.45e-05 | 267 | 154 | 10 | ctd:C009687 | |
| Drug | fluo-3 | 1.97e-05 | 122 | 154 | 7 | CID000104978 | |
| Drug | T0702 | 2.28e-05 | 25 | 154 | 4 | CID000005908 | |
| Drug | TMB-8 | 2.72e-05 | 176 | 154 | 8 | CID000005494 | |
| Drug | NSC-629231 | 3.51e-05 | 55 | 154 | 5 | CID000363885 | |
| Drug | PCB 95 | 3.52e-05 | 10 | 154 | 3 | CID000038012 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 4.55e-05 | 2 | 154 | 2 | ctd:C005147 | |
| Drug | honokiol | 4.55e-05 | 58 | 154 | 5 | CID000072303 | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.69e-05 | 190 | 154 | 8 | 3253_DN | |
| Drug | PCB 66 | 4.81e-05 | 11 | 154 | 3 | CID000036185 | |
| Drug | R 478 | 4.81e-05 | 11 | 154 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 4.81e-05 | 11 | 154 | 3 | CID003081323 | |
| Drug | H2O2 | SP1 PNKP NOX5 NPEPPS PARP2 BARD1 CASP6 HMGB1 XRCC5 ADAR CLCC1 RYR1 RYR2 RYR3 PARP1 PPIG H3C1 NFKB1 CYCS H3-3A PRKCG | 4.95e-05 | 1183 | 154 | 21 | CID000000784 |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 5.24e-05 | 193 | 154 | 8 | 997_UP | |
| Drug | Adenosine Triphosphate | 5.24e-05 | 193 | 154 | 8 | ctd:D000255 | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 5.43e-05 | 194 | 154 | 8 | 3316_DN | |
| Drug | borate | 5.48e-05 | 98 | 154 | 6 | CID000007628 | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 1692_DN | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 7071_UP | |
| Drug | M3/M4 | 6.25e-05 | 32 | 154 | 4 | CID000486507 | |
| Drug | Ryanodine | 6.38e-05 | 12 | 154 | 3 | ctd:D012433 | |
| Drug | nonivamide | 6.38e-05 | 12 | 154 | 3 | CID000002998 | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; HL60; HG-U133A | 6.50e-05 | 199 | 154 | 8 | 1439_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 6996_DN | |
| Drug | AC1L1DN5 | 6.85e-05 | 102 | 154 | 6 | CID000002423 | |
| Drug | Methamphetamine | FLNA FLNB TRPV1 NKX6-2 MAP4 SWT1 MAPT MYT1 BARD1 GIGYF1 CIC PCGF6 PARP1 RBM25 AHNAK NFKB1 BANP CYCS H3-3A MLLT6 IFT80 SPTY2D1 DUSP11 | 6.97e-05 | 1401 | 154 | 23 | ctd:D008694 |
| Drug | 2,4,4'-trichlorobiphenyl | FLNA PADI4 MOGAT1 RGS7BP FAM13C SMCHD1 MYT1 BARD1 DAPK1 HMGB2 PPFIA3 ITPRID1 UBN2 CEMIP FAT2 TNRC18 H3C1 SYTL5 ASPH CKAP4 KIF18B ATP2B3 IQGAP3 | 7.76e-05 | 1411 | 154 | 23 | ctd:C081766 |
| Drug | AH 23848 | 7.97e-05 | 34 | 154 | 4 | ctd:C046926 | |
| Drug | C13932 | 8.27e-05 | 206 | 154 | 8 | CID000168297 | |
| Drug | cupric oxide | H1-10 SP1 TBC1D9B ABCF1 MAP4 NACA BARD1 DAPK1 HMGB2 STRAP AHNAK KIF18B ALPK2 | 8.56e-05 | 543 | 154 | 13 | ctd:C030973 |
| Drug | E-PEG | SP1 PARP2 CASP6 SIN3A MED1 XRCC5 PARP1 H3C1 NFKB1 CYCS SMARCB1 H3-3A POLDIP2 EN2 | 8.62e-05 | 621 | 154 | 14 | CID000003310 |
| Drug | Butyrates | 8.85e-05 | 208 | 154 | 8 | ctd:D002087 | |
| Drug | d(GpG | 8.95e-05 | 35 | 154 | 4 | CID000161113 | |
| Drug | ADP-Rib | 9.35e-05 | 269 | 154 | 9 | CID000000192 | |
| Drug | strontium | 9.81e-05 | 68 | 154 | 5 | CID000104798 | |
| Drug | Aroclor 1254 | 1.04e-04 | 213 | 154 | 8 | CID000040470 | |
| Drug | 6-isopropoxy-9-oxoxanthene-2-carboxylic acid | 1.12e-04 | 37 | 154 | 4 | ctd:C053876 | |
| Drug | AC1O5KXC | 1.12e-04 | 37 | 154 | 4 | CID006436011 | |
| Drug | mag-fura-2 | 1.12e-04 | 37 | 154 | 4 | CID000123839 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 1.12e-04 | 37 | 154 | 4 | CID000009643 | |
| Drug | NSC105327 | 1.13e-04 | 70 | 154 | 5 | CID005318433 | |
| Drug | flavopiridol | 1.15e-04 | 216 | 154 | 8 | CID005287969 | |
| Drug | AC1L1D8L | 1.21e-04 | 71 | 154 | 5 | CID000002241 | |
| Drug | fludarabine | 1.21e-04 | 71 | 154 | 5 | ctd:C024352 | |
| Drug | AC1L98DX | 1.24e-04 | 38 | 154 | 4 | CID000439957 | |
| Drug | FPL 64176 | 1.30e-04 | 15 | 154 | 3 | CID000003423 | |
| Drug | dehydroxymethylepoxyquinomicin | 1.30e-04 | 15 | 154 | 3 | ctd:C464444 | |
| Drug | Gvapspat amide | 1.30e-04 | 15 | 154 | 3 | CID000125015 | |
| Drug | N-alpha-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)ornithine amide | 1.36e-04 | 3 | 154 | 2 | ctd:C568519 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.36e-04 | 3 | 154 | 2 | CID000080262 | |
| Drug | flubendiamide | 1.36e-04 | 3 | 154 | 2 | CID011193251 | |
| Drug | Caspase Inhibitor I | 1.88e-04 | 78 | 154 | 5 | CID000004339 | |
| Drug | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | 1.92e-04 | 17 | 154 | 3 | ctd:C523166 | |
| Drug | kazinol B | 1.92e-04 | 17 | 154 | 3 | CID000480869 | |
| Drug | NSC683246 | 1.99e-04 | 234 | 154 | 8 | CID000005097 | |
| Drug | sanglifehrin A | 2.21e-04 | 44 | 154 | 4 | CID005388925 | |
| Drug | cADPR | 2.38e-04 | 82 | 154 | 5 | CID000123847 | |
| Drug | 4,4'-dithiodipyridine | 2.42e-04 | 45 | 154 | 4 | CID000075846 | |
| Drug | YF-1 | 2.52e-04 | 83 | 154 | 5 | CID000445779 | |
| Drug | XeC compound | 2.66e-04 | 84 | 154 | 5 | CID000005701 | |
| Drug | A-30 | 2.70e-04 | 4 | 154 | 2 | CID003028528 | |
| Drug | propolin B | 2.70e-04 | 4 | 154 | 2 | CID000637252 | |
| Drug | Bastadin 10 | 2.70e-04 | 4 | 154 | 2 | CID009589366 | |
| Drug | chloramphenicol oxamic acid | 2.70e-04 | 4 | 154 | 2 | CID000084004 | |
| Drug | ebselen | 2.71e-04 | 131 | 154 | 6 | CID000003194 | |
| Drug | luteolin | 2.71e-04 | 131 | 154 | 6 | CID005280445 | |
| Drug | AC1MW7VF | 2.72e-04 | 19 | 154 | 3 | CID000414699 | |
| Drug | 2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione | 2.72e-04 | 19 | 154 | 3 | ctd:C562254 | |
| Drug | AC1L380G | 2.72e-04 | 19 | 154 | 3 | CID000084698 | |
| Drug | apocynin | 2.81e-04 | 186 | 154 | 7 | CID000002214 | |
| Drug | Zlllal | NACA CASP6 XPC MED1 PARP1 H3C1 NFKB1 CYCS PKNOX1 SMARCB1 H3-3A PRKCG AATF | 2.81e-04 | 613 | 154 | 13 | CID000107707 |
| Drug | carmustine; Up 200; 100uM; PC3; HT_HG-U133A | 2.90e-04 | 187 | 154 | 7 | 6883_UP | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.37e-07 | 3 | 153 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.37e-07 | 3 | 153 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | congestive heart failure (implicated_via_orthology) | 6.06e-05 | 41 | 153 | 4 | DOID:6000 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 7.99e-05 | 3 | 153 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 7.99e-05 | 3 | 153 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 8.25e-05 | 85 | 153 | 5 | C1510586 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.23e-04 | 49 | 153 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement, mortality | 2.64e-04 | 5 | 153 | 2 | EFO_0004352, EFO_0007044, EFO_0007892 | |
| Disease | lymphocyte measurement | 3.69e-04 | 117 | 153 | 5 | EFO_0803546 | |
| Disease | GLIOMA SUSCEPTIBILITY 1 | 3.95e-04 | 6 | 153 | 2 | C2750850 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.57e-04 | 195 | 153 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | white matter volume measurement | 6.07e-04 | 32 | 153 | 3 | EFO_0008320 | |
| Disease | Obesity | 7.23e-04 | 205 | 153 | 6 | C0028754 | |
| Disease | Profound Mental Retardation | 8.08e-04 | 139 | 153 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 8.08e-04 | 139 | 153 | 5 | C0025363 | |
| Disease | Mental deficiency | 8.08e-04 | 139 | 153 | 5 | C0917816 | |
| Disease | obesity (implicated_via_orthology) | 9.26e-04 | 215 | 153 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0008200 | |
| Disease | tauopathy (implicated_via_orthology) | 1.17e-03 | 10 | 153 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | vitamin B6 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0004621 | |
| Disease | 2-ketocaprylate measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0800110 | |
| Disease | erectile dysfunction | 1.35e-03 | 42 | 153 | 3 | EFO_0004234 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.42e-03 | 93 | 153 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | N-acetylphenylalanine measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0800019 | |
| Disease | methionine sulfone measurement | 1.70e-03 | 12 | 153 | 2 | EFO_0800072 | |
| Disease | N-acetyl-2-aminooctanoate measurement | 1.70e-03 | 12 | 153 | 2 | EFO_0800567 | |
| Disease | Congenital muscular dystrophy | 1.70e-03 | 12 | 153 | 2 | cv:C0699743 | |
| Disease | cortical surface area measurement | SP1 FLNB MAPT RBBP5 MYO9B MYT1 DAPK1 PLXND1 DNAH7 AXIN1 AFAP1L1 SP8 PCGF6 TIGD2 NFKB1 NAV1 | 1.72e-03 | 1345 | 153 | 16 | EFO_0010736 |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.92e-03 | 169 | 153 | 5 | DOID:3908 (is_marker_for) | |
| Disease | myopathy (implicated_via_orthology) | 1.99e-03 | 48 | 153 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Respiratory Depression | 2.01e-03 | 13 | 153 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.01e-03 | 13 | 153 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.01e-03 | 13 | 153 | 2 | C1145670 | |
| Disease | N-acetylglutamine measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0800017 | |
| Disease | cortical thickness | SP1 FLNB MAPT POLR1C PLXND1 BTBD1 PPID AFAP1L1 SP8 LMX1A TSPAN10 NFKB1 NAV1 FAM3C | 2.02e-03 | 1113 | 153 | 14 | EFO_0004840 |
| Disease | creatinine measurement | SIPA1L3 TPPP PRR22 SCLY SIN3A MED1 TUB RYR1 CEMIP ALMS1 NFKB1 ARID5B DUSP11 | 2.10e-03 | 995 | 153 | 13 | EFO_0004518 |
| Disease | QRS-T angle | 2.29e-03 | 106 | 153 | 4 | EFO_0020097 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.59e-03 | 181 | 153 | 5 | DOID:684 (is_implicated_in) | |
| Disease | mean platelet volume | LRRC66 NRDC RBBP5 MYO9B NPEPPS NACA ANKMY1 BRD3 SIN3A PLXND1 TNFRSF21 HMGB1P1 SP8 | 2.60e-03 | 1020 | 153 | 13 | EFO_0004584 |
| Disease | Huntington's disease (is_marker_for) | 2.65e-03 | 53 | 153 | 3 | DOID:12858 (is_marker_for) | |
| Disease | 3-hydroxyanthranilic acid measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0010447 | |
| Disease | reticulocyte measurement | SP1 FLNA FLNB MAPT MYO9B ASH1L GRB14 BRD3 HMGB1P1 RBM25 AHNAK NFKB1 PRKAA1 | 3.41e-03 | 1053 | 153 | 13 | EFO_0010700 |
| Disease | glutarylcarnitine (C5-DC) measurement | 3.45e-03 | 17 | 153 | 2 | EFO_0800030 | |
| Disease | Brain Ischemia | 3.77e-03 | 60 | 153 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 3.77e-03 | 60 | 153 | 3 | C0917798 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.31e-03 | 19 | 153 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 4.31e-03 | 19 | 153 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 4.52e-03 | 64 | 153 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | hippocampal volume | 4.65e-03 | 297 | 153 | 6 | EFO_0005035 | |
| Disease | myocardial infarction (implicated_via_orthology) | 4.93e-03 | 66 | 153 | 3 | DOID:5844 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLEKGRVKLPSHSDG | 1411 | Q9UPW8 | |
| SGQGKHGKKQLDPLT | 271 | Q8N9N5 | |
| PRIKLKLFGHSGSGK | 686 | P53355 | |
| GPNGKGKTTLLKHIA | 336 | Q8NE71 | |
| HSLSHKGKKLSSGKG | 306 | P55198 | |
| GEVPQHAGKKGKLSE | 296 | Q15059 | |
| IVPGLVHKESGKKLG | 346 | Q9NR48 | |
| VKKPKLSGSGTHSHG | 21 | Q6DCA0 | |
| HPKDNLIKLVTAGGG | 686 | Q99728 | |
| KGAHPSGGADDVAKK | 21 | Q07065 | |
| EGKHPEKLGGSAESL | 721 | Q2M2I8 | |
| EAPGSGHLAEGVKKK | 1716 | Q86TB3 | |
| GFGKQLPGDKRTKHI | 126 | Q86SQ3 | |
| APKHLKAGDTSKGGI | 471 | Q8TCU4 | |
| GLKGQKGTKGASGLH | 1181 | P53420 | |
| LKGAKPQGHIGVDAS | 386 | Q09666 | |
| VSLEGGKVKGKHGKL | 5806 | Q09666 | |
| TKHGGHKNGRKGGLS | 36 | Q12797 | |
| KGGGALLHSVKAKTQ | 431 | Q8IV53 | |
| GKGGALELHGQKKLS | 146 | Q8WUJ3 | |
| KKIKIEHAPSPSSGG | 516 | Q14004 | |
| AKKATPGAHTGAIPK | 256 | Q7L311 | |
| SQLKCLKEAGHGPGK | 1061 | Q16720 | |
| FHRKGKEPGGGTKSL | 151 | Q6MZT1 | |
| VGKHLGARKDHPGLK | 61 | P49756 | |
| HKPGGSGLTGAKLQD | 236 | Q96B26 | |
| LPKGKHSVKGLGKTT | 941 | P09874 | |
| GSPALAKVLKGHCEK | 741 | Q96PH1 | |
| EGLLQGKHSTKGLGK | 506 | Q9UGN5 | |
| GKHSTKGLGKMAPSS | 511 | Q9UGN5 | |
| LFGGKGKGSPSHRKH | 201 | Q15118 | |
| DIAHGPPAKKKSTGS | 51 | Q9UM07 | |
| ENPAGHGSKEVKGKT | 116 | Q9Y2S7 | |
| GGKGIKTKSPFEQHI | 186 | Q92520 | |
| LKGKSHKPVGCLGEA | 526 | P23352 | |
| LGGAKESLDAHPGKF | 186 | Q96PD6 | |
| GSKLGHSNKADKGPS | 236 | Q9Y250 | |
| SKCGSKDNIKHVPGG | 1006 | P27816 | |
| SKANIKHKPGGGDVK | 1041 | P27816 | |
| NHSTKLGPGEGSKAK | 991 | O75420 | |
| EHPGLSIGDVAKKLG | 116 | P09429 | |
| KLKSLSHLAGKGPDS | 371 | Q6ZRS4 | |
| EHPGLSIGDTAKKLG | 116 | P26583 | |
| ARKSAPSTGGVKKPH | 26 | P84243 | |
| AHKAKKAAPGAAGSR | 141 | Q92522 | |
| GSEGTPDSLHKAPKK | 746 | O75145 | |
| GLFKGDKCHSLVGKP | 141 | P55212 | |
| ARKSAPATGGVKKPH | 26 | Q5TEC6 | |
| SKVKAHGPGLEGGLV | 1041 | O75369 | |
| KGKIDAKVHSPSGAV | 2316 | O75369 | |
| HRSEGGLVDKGPLKK | 241 | A6NKB5 | |
| IGTKSKDLPSGPEKH | 336 | Q63HM2 | |
| ICLPHGAGGDAKKLT | 321 | Q9Y4D7 | |
| VVGGDPGKHFKAIKS | 291 | Q9NYQ8 | |
| AGKGTAEEGKDHKRP | 181 | Q8TE12 | |
| KCVKGKGSLPLSAHG | 26 | Q9Y4W2 | |
| AEAPPGSKRKGKVHG | 31 | A0A087WXM9 | |
| PAKLIGHGVKGVSSL | 611 | Q6ZN66 | |
| ARKSAPATGGVKKPH | 26 | Q16695 | |
| CKGFLTKHPGKRLGS | 586 | P05129 | |
| AGASHKGDEVPPIKK | 181 | O75167 | |
| ARKSAPATGGVKKPH | 26 | P68431 | |
| GTHDGPKKKGKDLTF | 56 | Q86Y91 | |
| LDHLAPDSKSSGKGK | 1516 | Q86VI3 | |
| GGRHTGISTLGKKAK | 326 | Q68CR7 | |
| EVHPLLGVKGDGKSK | 466 | Q15291 | |
| GEKGTGKSTQKPLHY | 46 | Q13427 | |
| TKAGHGAGKPTAKVI | 676 | P48147 | |
| STGKPLGDGKFLSHK | 446 | Q9P2H3 | |
| GTHSHKLFKKLGIPG | 26 | Q9HB55 | |
| VEKGGKHKTGPNLHG | 21 | P99999 | |
| KHKTGPNLHGLFGRK | 26 | P99999 | |
| GRSSAKKKGGNHIPE | 66 | O75319 | |
| TTAHDLSGKLGTPKK | 156 | P55265 | |
| KGAIDAKVHSPSGAL | 2361 | P21333 | |
| GPDSHYGTKGLKKVV | 431 | Q9H0C5 | |
| SGHGKHVPKSGAKLD | 511 | O15169 | |
| GPSTSKSKGKSPHKE | 106 | Q8WXX0 | |
| LKGDSPLVKGSLGHV | 431 | Q9P2S6 | |
| PKGGTLHADAQLSGK | 606 | Q86UW7 | |
| SLAGKKKHGAPTNYG | 291 | Q14449 | |
| GGSKTLSLHGGAKKG | 156 | P19622 | |
| PAKVLGSGGHASNKE | 3021 | P21817 | |
| DENKKHGLPGIGLST | 1741 | Q92736 | |
| RGLVLGKLGKAGHKA | 706 | P55786 | |
| KHDGGSPSIKAKVTL | 1396 | Q15648 | |
| GANEGTGHFKPLEKK | 261 | Q9BYE7 | |
| LGAMGDHSKKKPGTA | 11 | Q96A47 | |
| SSKGGELKKPISLGH | 511 | Q8NEY1 | |
| KKFPTGGKHETVGGQ | 126 | Q4VX76 | |
| VAGKKASHDGPKRKG | 171 | Q8TDW5 | |
| ASHDGPKRKGFLLSK | 176 | Q8TDW5 | |
| QKLPGTSHGGSKKLL | 731 | A6NHR9 | |
| PGCGKVYGKTSHLKA | 301 | Q6BEB4 | |
| GEKSSTPIKGPKRGH | 321 | O75509 | |
| PKKAKGGGEAVETHP | 26 | Q7Z572 | |
| APAGGVLDKDGKKKH | 136 | Q9C056 | |
| DGSSKNKRGVLPKHA | 256 | P55347 | |
| PSKKSGPQVKLSGSH | 261 | Q15761 | |
| KGGPVFGEKHSKSPA | 216 | Q8WZA1 | |
| KGIGHTTGKPLHFKG | 56 | Q08752 | |
| ARKSAPATGGVKKPH | 26 | Q71DI3 | |
| EHPGLSIGDVAKKLG | 116 | B2RPK0 | |
| ATKHGTGRGLPLKDA | 571 | O60292 | |
| VKKHNGVGGSPPKSK | 851 | Q96ST3 | |
| SSHGKKTKPNTKDHG | 66 | Q12824 | |
| LHGPAGVGKTTLAKK | 176 | Q8WX94 | |
| VGFPGAGKSTFLKKH | 371 | Q96T60 | |
| KGIGKDHAKFSPVAT | 216 | O15160 | |
| KPKSIFKAESGRSHG | 91 | Q8NE31 | |
| GSGDPGKKKQHICHI | 616 | P08047 | |
| GSKLDHGIKSLSSPK | 141 | Q5T5J6 | |
| GLGNTASGAPHKVKK | 1326 | Q7Z745 | |
| KLSKGSGDRHPSSKG | 241 | Q68D10 | |
| PKEISGHTSGIKKAL | 136 | Q9Y3F4 | |
| PGCGKVYGKTSHLKA | 361 | Q8IXZ3 | |
| DPQAKAGGDTHLGKA | 1106 | Q66K14 | |
| GTFGKVKVGKHELTG | 36 | Q13131 | |
| KGGPEFSSALKNSHK | 266 | Q9NY61 | |
| HGKGKKSSLAELKGS | 371 | Q8TED9 | |
| KPTGKVLGLAHSTTG | 916 | Q14865 | |
| AKPTSLGLAGGHKET | 281 | Q96RK0 | |
| PLKHIGKGTGEFIKA | 311 | Q96S66 | |
| GALLGAGKAKAPKTA | 261 | Q8IZ63 | |
| QAGKARPSAHSPGKK | 2706 | O15417 | |
| QRHGIPKAAGKGTKL | 131 | Q4W5G0 | |
| KGHTGGHHSPVKGAK | 121 | Q96I15 | |
| AALGKKHKGGDSSSG | 36 | Q8N511 | |
| HDGGQSKGDTKLPRK | 1331 | Q6ZU65 | |
| AAHGDFFKKTKGRPG | 231 | Q8NER1 | |
| RAKKGAEGKPPGHSS | 186 | O43818 | |
| PGAHAKVKKLFVGGL | 91 | Q13151 | |
| KKLELESKGGGSHPL | 2751 | Q15413 | |
| LFGLHPKKEGSLKHG | 4281 | Q15413 | |
| HLQPKEMKSSAGGKG | 401 | Q14765 | |
| THAKKKPVSGGSVGK | 336 | Q9HAH1 | |
| KVATFKKPGVSGHGV | 806 | Q8IWV7 | |
| ASGKAKLTHPGKAIL | 16 | P53007 | |
| KLTHPGKAILAGGLA | 21 | P53007 | |
| GHEGKGSILSFLRKK | 466 | O43847 | |
| LKALHSRGDGGPKAL | 316 | Q9NQQ7 | |
| SKCGSKDNIKHVPGG | 606 | P10636 | |
| PGGGNKKIETHKLTF | 681 | P10636 | |
| AKVTQTPGHLVKGKG | 21 | A0A0A0MS06 | |
| ETKHQALSGTPKKGP | 51 | Q9H1Z9 | |
| HKERFDPSGKGKGKA | 176 | O94811 | |
| LSHGSKEKALFLPGG | 76 | O95201 | |
| DSKGASKDLPGHFLK | 841 | Q9ULD9 | |
| SAGHKAKGVISGVGK | 3786 | Q7Z7G8 | |
| KGHDTHKGKPVKTGS | 106 | Q9UPP1 | |
| TKGFGHKPGLKKHPA | 431 | Q6NUN9 | |
| SHPGGSADGPAKKKV | 61 | Q01831 | |
| HAGGKSSQKSPELGK | 736 | Q9UEG4 | |
| GKDPTSGAKDGKSLL | 301 | A4D1P6 | |
| HHRKGTKGSEDSPPK | 431 | P48651 | |
| EKKGKHKGTSGPAAL | 126 | P50607 | |
| SHSAGTKAPALKGGA | 481 | Q8TD43 | |
| GPTAKKLKTEQGGAH | 561 | P13010 | |
| DSSDGITGKKKGGHV | 1036 | B1ANS9 | |
| KFTVDLPKKHGRGGQ | 171 | P62495 | |
| SKTAKGKDASHSPKG | 1746 | E9PAV3 | |
| HAAGEKRTKEPGGKG | 1466 | Q13459 | |
| AGKKGKLSGDEVLSP | 976 | Q01538 | |
| HGGLPGASSEKNKKS | 66 | P19838 |